0001493152-19-016747.txt : 20191112 0001493152-19-016747.hdr.sgml : 20191112 20191108205137 ACCESSION NUMBER: 0001493152-19-016747 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 68 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20191112 DATE AS OF CHANGE: 20191108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Agape ATP Corp CENTRAL INDEX KEY: 0001713210 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 364838886 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-220144 FILM NUMBER: 191205462 BUSINESS ADDRESS: STREET 1: 1705-1708 LEVEL 17, TOWER 2, FABER TOWER STREET 2: JALAN DESA BAHAGIA, TAMAN DESA CITY: KUALA LUMPUR STATE: N8 ZIP: 58100 BUSINESS PHONE: (603) 27325716 MAIL ADDRESS: STREET 1: 1705-1708 LEVEL 17, TOWER 2, FABER TOWER STREET 2: JALAN DESA BAHAGIA, TAMAN DESA CITY: KUALA LUMPUR STATE: N8 ZIP: 58100 10-Q 1 form10-q.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

For The Quarterly Period Ended September 30, 2019

 

or

 

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______________ to _______________

 

Commission File Number 333-220144

 

AGAPE ATP CORPORATION

(Exact name of registrant issuer as specified in its charter)

 

Nevada   36-4838886

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

1705 - 1708, Level 17, Tower 2, Faber Tower, Jalan Desa Bahagia,
Taman Desa, 58100 Kuala Lumpur, Malaysia.

(Address of principal executive offices, including zip code)

 

Registrant’s phone number, including area code (60) 192230099

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:   Trading Symbol(s)   Name of each exchange on which registered:
Common Stock   AATP   The OTC Market – Pink Sheets

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

YES [X] NO [  ]

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding twelve months (or shorter period that the registrant was required to submit and post such files).

 

YES [X] NO [  ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer [  ] Accelerated Filer [X] Non-accelerated Filer [  ] Smaller reporting company [  ]

Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Yes [  ] No [X]

 

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY

PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

 

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.

 

Yes [  ] No [  ]

 

APPLICABLE ONLY TO CORPORATE ISSUERS:

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class   Outstanding at November 8, 2019
Common Stock, $.0001 par value   376,275,500

 

 

 

 
 

 

TABLE OF CONTENTS

 

    Page
PART I FINANCIAL INFORMATION  
ITEM 1. UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS: F-1
  Consolidated Balance Sheets as of September 30, 2019 (unaudited) and June 30, 2019 (audited) F-2
  Consolidated Statements of Operations and Comprehensive Losses for the Three Months Ended September 30, 2019 and 2018 (unaudited) F-3
  Consolidated Statements of Changes in Stockholders’ Equity for the Three Months Ended September 30,2019 (unaudited) F-4
  Consolidated Statements of Cash Flows for the Three Months Ended September, 2019 and 2018 (unaudited) F-5
  Notes to the Consolidated Financial Statements F-6 - F-18
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 3
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 6
ITEM 4. CONTROLS AND PROCEDURES 6
PART II OTHER INFORMATION  
ITEM 1 LEGAL PROCEEDINGS 8
ITEM 1A RISK FACTORS 8
ITEM 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 14
ITEM 3 DEFAULTS UPON SENIOR SECURITIES 14
ITEM 4 MINE SAFETY DISCLOSURES 14
ITEM 5 OTHER INFORMATION 14
ITEM 6 EXHIBITS 15
  SIGNATURES 16

 

2
 

 

PART I FINANCIAL INFORMATION

 

ITEM 1. UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS:

 

AGAPE ATP CORPORATION

CONSOLIDATED FINANCIAL STATEMENTS

 

  Page
Consolidated Financial Statements  
   
Consolidated Balance Sheets as of September 30, 2019 (unaudited) and June 30, 2019 (audited) F-2
Consolidated Statements of Operations and Comprehensive Losses for the Three Months Ended September 30, 2019 and 2018 (unaudited) F-3
Consolidated Statements of Changes in Stockholders’ Equity for the Three Months Ended September 30,2019 (unaudited) F-4
Consolidated Statements of Cash Flows for the Three Months Ended September 30, 2019 and 2018 (unaudited) F-5
Notes to the Consolidated Financial Statements F-6 - F-18

 

F-1
 

 

AGAPE ATP CORPORATION

CONSOLIDATED BALANCE SHEETS

AS OF SEPTEMBER 30, 2019 AND JUNE 30, 2019

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

   As of
September 30, 2019
   As of
June 30, 2019
 
    Unaudited    Audited 
ASSETS          
NON-CURRENT ASSETS          
Investment in marketable securities  $134,166   $134,166 
Investment in non-marketable securities   726,119    726,119 
Total Non-Current Assets  $860,285   $860,285 
           
CURRENT ASSETS          
Cash and cash equivalents  $2,753,080   $2,857,587 
Trade receivables   628,583    511,610 
Prepayments and deposits   362,049    498,335 
Amount due from a related party   2,202    2,210 
Total Current Assets  $3,745,914   $3,869,742 
           
TOTAL ASSETS  $4,606,199   $4,730,027 
           
STOCKHOLDERS’ EQUITY AND LIABILITIES          
STOCKHOLDERS’ EQUITY          
Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding   -    - 
Common Stock, par value $0.0001; 1,000,000,000 shares authorized, 376,275,500 and 376,275,500 issued and outstanding as of September 30, 2019 and June 30, 2019  $37,628   $37,628 
Additional paid in capital   5,293,082    5,293,082 
Accumulated other comprehensive income/(losses)   (3,387)   (79)
Accumulated losses   (848,342)   (750,278)
TOTAL STOCKHOLDERS’ EQUITY  $4,478,981   $4,580,353 
           
CURRENT LIABILITIES          
Trade payables  $-   $35,145 
Other payables and accrued liabilities   123,292    110,591 
Amount due to a director   3,926    3,938 
Total Current Liabilities  $127,218   $149,674 
           
TOTAL LIABILITIES  $127,218   $149,674 
           
TOTAL STOCKHOLDERS’ EQUITY AND LIABILITIES  $4,606,199   $4,730,027 

 

See accompanying notes to consolidated financial statements.

 

F-2
 

 

AGAPE ATP CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSSES

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019 and 2018

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

   Three Months Ended September 30, 
   2019   2018 
   Unaudited   Unaudited 
REVENUE  $236,736   $415,367 
           
COST OF REVENUE   (210,383)   (378,423)
           
GROSS PROFIT   26,353    36,944 
           
OTHER INCOME   19,865    1,621 
           
SELLING, GENERAL AND ADMINISTRATIVE AND OPERATING EXPENSES   (144,282)   (118,618)
           
LOSS BEFORE RESULTS OF INVESTEE COMPANY   (98,064)   (80,053)
           
SHARE OF RESULTS OF INVESTEE COMPANY   -    (52,109)
           
LOSS BEFORE INCOME TAX   (98,064)   (132,162)
           
TAXATION   -    (3,704)
           
NET LOSS  $(98,064)  $(135,866)
Other comprehensive income/(loss):          
- Foreign currency translation adjustment   (3,308)   - 
TOTAL COMPREHENSIVE LOSS  $(101,372)  $(135,866)
           
Net loss per share- Basic and diluted  $(0.00)  $(0.00)
           
Weighted average number of common shares outstanding - Basic and diluted   376,275,500    376,275,500 

 

See accompanying notes to consolidated financial statements.

 

F-3
 

 

AGAPE ATP CORPORATION

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

   COMMON STOCK   ADDITIONAL   ACCUMULATED OTHER         
   Number of
shares
   Amount   PAID-IN
CAPITAL
   COMPREHENSIVE
INCOME/(LOSS)
   ACCUMULATED
LOSSES
   TOTAL
EQUITY
 
Balance as of June 30, 2019 (audited)   376,275,600   $37,628   $5,293,082   $(79)  $(750,278)  $4,580,353 
Foreign currency translation adjustment   -    -    -    (3,308)   -    (3,308)
Net loss for the period   -    -    -    -    (98,064)   (98,064)
Balance as of September 30, 2019 (unaudited)   376,275,600   $37,628   $5,293,082   $(3,387)  $(848,342)  $4,478,981 

 

See accompanying notes to consolidated financial statements

 

F-4
 

 

AGAPE ATP CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019 and 2018

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

   Three months ended September 30, 
   2019   2018 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(98,064)  $(135,866)
Adjustments to reconcile net loss to net cash used in operating activities:          
Share of result of investee company   -    52,109 
Taxation   -    3,704 
Changes in operating assets and liabilities:          
Accounts receivables   (116,973)   (13,264)
Prepayments and deposits   136,286    (107,250)
Amount due from a related party   8    - 
Accounts payables   (35,145)   47,641 
Other payables and accrued liabilities   12,701    (12,000)
Deposit received   -    471,931 
Amount due to director   (12)   - 
           
Net cash (used in) / provided by operating activities  $(101,199)  $307,005 
           
Effect of exchange rate changes on cash and cash equivalents   (3,308)   - 
           
Net change in cash and cash equivalents   (104,507)   307,005 
Cash and cash equivalents, beginning of period   2,857,587    3,531,255 
CASH AND CASH EQUIVALENTS, END OF PERIOD  $2,753,080   $3,838,260 
           
SUPPLEMENTAL CASH FLOWS INFORMATION          
Income taxes paid  $-   $- 
Interest paid  $-   $- 

 

See accompanying notes to consolidated financial statements.

 

F-5
 

 

AGAPE ATP CORPORATION

NOTES TO FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

1. ORGANIZATION AND BUSINESS BACKGROUND

 

Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016.

 

Agape ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.

 

Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.

 

The Company and its subsidiaries are involved in the health and wellness industry. The principal activity of the Company and its subsidiaries is to supply high-quality health and wellness products, including supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in our body.

 

Details of the Company’s subsidiaries:

 

   Subsidiary
company name
  Place and date of
incorporation
  Particulars of
issued capital
  Principal
activities
  Proportional of
ownership interest
and voting power held
 
1.  Agape ATP Corporation  Labuan,
March 6, 2017
  100 shares of ordinary share of US$1 each  Investment holding   100%
                  
2.  Agape ATP International Holding Limited  Hong Kong,
June 1, 2017
  1,000,000 shares of ordinary share of HK$1 each  Health and wellness products and health solution advisory services   100%

 

Business Overview

 

Agape ATP Corporation is a company that develops and provides health solution advisory services to our clients. We primarily focus our efforts on attracting customers in Malaysia. Our advisory services center on the “ATP Zeta Health Program”, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.

 

At its core, the ATP Zeta Super Health Program is focused upon biological energy, Adenosine Triphosphate (ATP), at the cellular level. The stimulation of ATP production at the cellular level can increase the metabolism and service to promote and maintain normal and healthy functioning of the body’s systems. As a strong advocator of “beauty from within”, our program shall emphasize nutrient absorption through the membrane ion channel to provide complete and balanced nutrients to improve cell health. Thus, ATP Zeta Super Health Program provides ionized and high zeta potential (high bioavailability) nutrients to enhance the absorption at the cellular level.

 

F-6
 

 

AGAPE ATP CORPORATION

NOTES TO FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

The ATP Zeta Super Health Program consists of ten products. None of these products are owned or produced by Agape ATP Corporation. In the event that any of these products are no longer produced, or are otherwise unavailable, we may have to devote significant effort to identifying and obtaining comparable replacement products. The ten products that comprise the ATP Zeta Super Health Program are ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, ATP5 BetaMaxx, AGN-Vege Fruit Fiber, AGP1-Iron, YFA-Young Formula, Mitogize and ORYC-Organic Youth Care Cleansing Bar.

 

At present, our products are mainly sold in Malaysia, and due to the contents and combination of the main ingredients in the products they are categorized as health food rather than medicines or drugs. As such, all products require authorization from the Food and Quality Division of Ministry of Health according to the Food Act of 1983 and Food Regulation 1985 in order to be sold in the country. All of the products in the ATP Zeta Super Health Program have obtained the appropriate authorizations.

 

As part of a continuous effort to increase market share of the health and wellness industry that is growing at an exponential rate, we will also evaluate adding additional products to the ATP Zeta Super Health Program; and considering the potential of the synergies between the health and beauty sectors, we will further involve ourselves in the topical approach of skin and hair regime.

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The accompanying consolidated financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying consolidated financial statements and notes.

 

Basis of presentation

 

These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

 

Basis of consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.

 

Use of estimates

 

In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

Investment in investee company

 

The Company evaluates investment in investee company as it holds an equity interest based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee.

 

F-7
 

 

AGAPE ATP CORPORATION

NOTES TO FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

Investment in marketable securities

 

Marketable securities included in marketable securities (current) and other investments (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities included in marketable securities (current) are stated at the lower of cost or market in the aggregate. and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary.

 

Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

 

Investment in non-marketable securities

 

Investments in non-marketable equity securities (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary.

 

Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.

 

Accounts receivable

 

Accounts receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on demand. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.

 

Revenue recognition

 

In accordance with ASC Topic 605, “Revenue Recognition”, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured.

 

Revenue from supplies of healthy food products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded. Based on limited operating history, management estimates that there was no sale return for the period reported.

 

F-8
 

 

AGAPE ATP CORPORATION

NOTES TO FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

Cost of revenue

 

Cost of revenue includes the purchase cost of manufactured goods for sale to customers It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

 

Selling, general, administrative and operating expenses

 

Selling, general, administrative and operating expenses are primarily comprised of rental of office premises, licensing and professional fees.

 

Income taxes

 

The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 

Net loss per share

 

The Company calculates net loss per share in accordance with ASC Topic 260 “Earnings per share”. Basic loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 

F-9
 

 

AGAPE ATP CORPORATION

NOTES TO FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates is the Malaysian Ringgit (“MYR”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to itss functional currency.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

 

Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:

 

   As of and for the three months
ended September 30,
 
   2019   2018 
         
Period-end MYR : US$1 exchange rate   4.19    4.14 
Period-average MYR : US$1 exchange rate   4.18    4.09 
Period-end HKD : US$1 exchange rate   7.84    7.83 
Period-average HKD : US$1 exchange rate   7.84    7.85 
Period-end AUD : US$1 exchange rate   1.48    - 
Period-average AUD : US$1 exchange rate   1.47    - 

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Fair value of financial instruments:

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.

 

F-10
 

 

AGAPE ATP CORPORATION

NOTES TO FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1: Observable inputs such as quoted prices in active markets;
   
  Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
   
  Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

 

Recent accounting pronouncements

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:

 

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605)”, and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. In August 2015, the FASB issued an Accounting Standards Update to defer by one year the effective dates of its new revenue recognition standard until annual reporting periods beginning after December 15, 2017 (2018 for calendar-year public entities) and interim periods therein. Management is currently assessing the impact of the adoption of ASU 2014-09 and has not determined the effect of the standard on our ongoing financial reporting.

 

In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. The Company is evaluating this ASU and has not determined the effect of this standard on its ongoing financial reporting.

 

F-11
 

 

AGAPE ATP CORPORATION

NOTES TO FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

In January 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business”, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This amendment was effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU No. 2017-01 did not have a material impact on the Company’s financial position, results of operations and liquidity.

 

In September 2017, the FASB has issued ASU No. 2017-13, Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.” The amendments in ASU No. 2017-13 amends the early adoption date option for certain companies related to the adoption of ASU No. 2014-09 and ASU No. 2016-02. Both of the below entities may still adopt using the public company adoption guidance in the related ASUs, as amended. The effective date is the same as the effective date and transition requirements for the amendments for ASU 2014-09 and ASU 2016-02.

 

In February 2018, the FASB has issued ASU No. 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220), which allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act. Consequently, the amendments eliminate the stranded tax effects resulting from the Tax Cuts and Jobs Act and will improve the usefulness of information in financial statement. The amendments in this ASU are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. The Company has analyzed the consequences of such adoption and has not determined the effect of this standard on its ongoing financial reporting.

 

In August 2018, the FASB has issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements of Fair Value Measurement. This amendment modifies the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, based on the concepts in the Concepts Statement, including the consideration of costs and benefits, with the primary purpose to improve the effectiveness of disclosures in the notes to financial statements by facilitating clear communication of the information required by US GAAP. The amendments in this update are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.

 

3. INVESTMENT IN MARKETABLE SECURITIES

 

(i) On May 17, 2018, the Company purchased common stocks in Greenpro Capital Corp. for $500,000 at purchase price of $6 per share.
   
(ii) On October 16, 2018, the Company purchased common stocks in Greenpro Capital Corp. for $1,000 at purchase price of $0.03 per share.

 

   As of
September 30, 2019
   As of
June 30, 2019
 
Cost of investment  $501,000   $501,000 
Less: Impairment in cost of investment   (366,834)   (366,834)
Investment in marketable securities  $134,166   $134,166 

 

F-12
 

 

AGAPE ATP CORPORATION

NOTES TO FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

4. INVESTMENT IN NON-MARKETABLE SECURITIES

 

The Company invested in Unreserved Sdn Bhd with the investment amount of $863,592 (MYR3,500,000), approximated 20% of equity interest of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. On March 10, 2019 Unreserved Sdn Bhd issued additional common stock for working capital. As the Company did not subscribe for the additional common stock, the Company’s equity interest in investee company was diluted from 20.0% to 17.86%. Effective March 10, 2019, the Company discontinued equity accounting on the investee company. The Company also ceased control over the operations of the investee company on the same date. Accordingly, investment in investee company was reclassified to investment in non-marketable securities.

 

Unreserved Sdn Bhd is incorporated in Malaysia with 2,500,000 ordinary shares authorized, issued and outstanding. Mr Lim Hun Soon @ David Lim and Ms Aniza Helina Akmi Karim are the directors of Unreserved Sdn Bhd. Mr How Kok Choong was a director of the company from April 30,2018 to March 27, 2019.

 

On April 3, 2019, the Company purchased 5% of 300,000,000 or 15,000,000 common stocks in Phoenix Plus Corp. for $1,500 at purchase price of $0.0001 per share.

 

Unreserved Sdn Bhd  As of
September 30, 2019
   As of
June 30, 2019
 
Cost of investment  $832,335   $832,335 
Less: share of result of investee company   (124,225)   (124,225)
Add: gain on deemed disposal of shares in investee company   16,509    16,509 
Investment in investee company  $724,619   $724,619 
Reclassify to investment in non-marketable securities   (724,619)   (724,619)
Investment in investee company  $-    - 
Investment in non-marketable securities  $724,619   $724,619 
           
Phoenix Plus Corporation        
Cost of investment  $1,500   $1,500 
           
Total investment in non-marketable securities  $726,119   $726,119 

 

5. CASH AND CASH EQUIVALENTS

 

As at September 30, 2019, the Company recorded $2,753,080 of cash and cash equivalents (June 30,2019: $2,857,587), which consists $265,691 of cash on hand (June 30,2019: $353,214) and $2,487,389 (June 30, 2019: $2,504,373) of time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments. The effective interest rate for the time deposits ranges between 2.95% to 3.25% per annum (September 30,2019: 2.95% to 3.25%).

 

F-13
 

 

AGAPE ATP CORPORATION

NOTES TO FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

6. TRADE RECEIVABLES

 

   As of    As of  
   September 30, 2019   June 30, 2019 
Trade receivables  $628,583   $511,610 
Total trade receivables  $628,583   $511,610 

 

7. PREPAYMENTS AND DEPOSITS

 

   As of    As of 
   September 30, 2019   June 30, 2019 
Prepaid expenses  $12,420   $21,081 
Deposits to supplier   349,629    477,254 
Total prepaid expenses and deposits  $362,049   $498,335 

 

8. RELATED PARTY TRANSACTIONS

 

   Three Months Ended September 30, 
   2019   2018   2019   2018 
   Revenue   Accounts Receivable, Trade 
Agape S.E.A. Sdn Bhd  $236,736   $415,367   $628,583   $745 

 

   Expenses paid on behalf   Accounts Payable, Non-trade 
Agape ATP (Asia) Limited  $    -   $    -   $2,204   $   - 

 

   Sundry Purchases   Accounts Payable, Non-trade 
Agape Superior Living Pty Ltd  $    -   $    -   $35,024   $   - 

 

Related parties   Relationships

Agape S.E.A. Sdn Bhd

 

Mr How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape S.E.A. Sdn Bhd

     

Agape Superior Living Pty Ltd

 

Mr How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of Agape Superior Living Pty Ltd

     

Agape ATP (Asia) Limited

  Mr How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape ATP (Asia) Limited.

 

F-14
 

 

AGAPE ATP CORPORATION

NOTES TO FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

9. STOCKHOLDERS’ EQUITY

 

As of September 30, 2019, and June 30, 2019, there were 376,275,500 of common stocks issued and outstanding. There was no common stock issued and outstanding from the IPO as of September 30, 2019.

 

There were no stock options, warrants or other potentially dilutive securities outstanding as of September 30, 2019.

 

10. OTHER PAYABLES AND ACCRUED LIABILITIES

 

   As of    As of  
   September 30, 2019   June 30, 2019 
Accrued audit fees   2,500    20,000 
Accrued professional fees   6,417    - 
Deposit received from customer   77,962    78,231 
Others   36,413    12,360 
Total payables and accrued liabilities  $123,292   $110,591 

 

11. INCOME TAXES

 

For the three months ended September 30, 2019 and 2018, the local (United States) and foreign components of loss before income taxes were comprised of the following:

 

   Three Months Ended September 30, 
   2019   2018 
Tax jurisdictions from:          
- Local  $(86,056)  $(21,497)
- Foreign, representing          
Labuan   (22,072)   (81,004)
Hong Kong   10,064    (29,661)
Loss before income tax  $(98,064)  $(132,162)

 

The provision for income taxes consisted of the following:

 

   Three Months Ended September 30, 
   2019   2018 
Current:          
- Local  $     -   $   - 
- Foreign   -    3,704 
           
Deferred:          
- Local   -    - 
- Foreign   -    - 
           
Income tax expense  $-   $3,704 

 

F-15
 

 

AGAPE ATP CORPORATION

NOTES TO FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Labuan and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:

 

United States of America

 

Agape ATP Corporation is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of September 30, 2019, the operations in the United States of America incurred $524,482 of cumulative net operating losses which can be carried forward to offset future taxable income. The net operating loss carry forwards begin to expire in 2038, if unutilized. The tax valuation allowance for September 30, 2019 and 2018 are $110,141 and $76,559 respectively.

 

Labuan

 

Under the current laws of the Labuan, Agape ATP Corporation is governed under the Labuan Business Activity Act, 1990. The tax charge for such company is based on 3% of net audited profit.

 

Hong Kong

 

Agape ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of 16.5% on its assessable income derived from Hong Kong. Business income derived outside the Special Administrative Region is not subject to Hong Kong Profits Tax.

 

The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of September 30, 2019 and June 30, 2019:

 

   As of
September 30, 2019
   As of
June 30, 2019
 
         
Deferred tax assets:          
Net operating loss carry forwards          
-United States of America   110,141    92,069 
-Hong Kong   -    - 
Less: valuation allowance   (110,141)   (92,069)
Deferred tax asset   -    - 

 

F-16
 

 

AGAPE ATP CORPORATION

NOTES TO FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

12. AMOUNT DUE TO A DIRECTOR

 

As of September 30, 2019 and June 30, 2019, a director of the Company advanced $3,926 and $3,938 respectively to the Company, which is unsecured, interest-free with no fixed repayment term, for working capital purpose. Imputed interest is considered insignificant.

 

13. CONCENTRATIONS OF RISKS

 

(a) Major customers

 

For the three months ended September 30, 2019, the customers who accounted for 10% or more of the Company’s revenues and its account receivables balance at period-end are presented as follows:

 

   For the three months ended
September 30, 2019
   As of
September 30, 2019
 
   Revenue   Percentage of revenue   Accounts
receivable
 
             
Customer A  $236,736    100%  $628,583 
Total:  $236,736    100%  $628,583 

 

For the three months ended September 30, 2018, the customers who accounted for 10% or more of the Company’s revenues and its account receivables balance at period-end are presented as follows:

 

   For the three months ended
September 30, 2018
   As of
September 30, 2018
 
   Revenue   Percentage of revenue   Accounts
receivable
 
             
Customer A  $415,367    100%  $13,264 
Total:  $415,367    100%  $13,264 

 

F-17
 

 

AGAPE ATP CORPORATION

NOTES TO FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

(b) Major vendors

 

For the three months ended September 30, 2019, the vendors who accounted for 10% or more of the Company’s purchases and its account payables balance at period-end are presented as follows:

 

   For the three months ended
September 30, 2019
   As of
September 30, 2019
 
   Purchases   Percentage of purchases   Accounts payable 
             
Vendor A  $210,383    100%  $- 
Total:  $210,383    100%  $- 

 

For the three months ended September 30, 2018, the vendors who accounted for 10% or more of the Company’s purchases and its account payables balance at period-end are presented as follows:

 

   For the three months ended
September 30, 2018
   As of
September 30, 2018
 
   Purchases   Percentage of purchases   Accounts payable 
             
Vendor A  $314,423    83%  $47,641 
Vendor B   64,000    17%   - 
Total:  $378,423    100%  $47,641 

 

(c) Credit risk

 

Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

 

(d) Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of RM$ converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

 

14. SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after September 30, 2019 up through the date the Company issued the audited consolidated financial statements. During this period, there was no subsequent event that required recognition or disclosure.

 

F-18
 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The information contained in this quarter report on Form 10-Q is intended to update the information contained in our Form 10-K, dated September 13, 2019, for the year ended June 30, 2019 and presumes that readers have access to, and will have read, the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other information contained in such Form 10-K. The following discussion and analysis also should be read together with our consolidated financial statements and the notes to the consolidated financial statements included elsewhere in this Form 10-Q.

 

The following discussion contains certain statements that may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements appear in a number of places in this Report, including, without limitation, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” These statements are not guarantees of future performance and involve risks, uncertainties and requirements that are difficult to predict or are beyond our control. Forward-looking statements speak only as of the date of this quarterly report. You should not put undue reliance on any forward-looking statements. We assume no responsibility to update the forward-looking statements contained in this transition report on Form 10-Q. The following should also be read in conjunction with the unaudited Consolidated Financial Statements and notes thereto that appear elsewhere in this report.

 

Business Overview

 

Agape ATP Corporation is a company that develops and provides health solution advisory services to our clients. We primarily focus our efforts on attracting customers in Malaysia. Our advisory services center on the “ATP Zeta Health Program”, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.

 

At its core, the ATP Zeta Super Health Program is focused upon biological energy, Adenosine Triphosphate (ATP), at the cellular level. The stimulation of ATP production at the cellular level can increase the metabolism and service to promote and maintain normal and healthy functioning of the body’s systems. As a strong advocator of “beauty from within”, our program shall emphasize nutrient absorption through the membrane ion channel to provide complete and balanced nutrients to improve cell health. Thus, ATP Zeta Super Health Program provides ionized and high zeta potential (high bioavailability) nutrients to enhance the absorption at the cellular level.

 

The ATP Zeta Super Health Program consists of ten products. None of these products are owned or produced by Agape ATP Corporation. In the event that any of these products are no longer produced, or are otherwise unavailable, we may have to devote significant effort to identifying and obtaining comparable replacement products. The ten products that comprise the ATP Zeta Super Health Program are ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, ATP5 BetaMaxx, AGN-Vege Fruit Fiber, AGP1-Iron, YFA-Young Formula, Mitogize and ORYC-Organic Youth Care Cleansing Bar.

 

At present, our products are mainly sold in Malaysia, and due to the contents and combination of the main ingredients in the products they are categorized as health food rather than medicines or drugs. As such, all products require authorization from the Food and Quality Division of Ministry of Health according to the Food Act of 1983 and Food Regulation 1985 in order to be sold in the country. All of the products in the ATP Zeta Super Health Program have obtained the appropriate authorizations.

 

3
 

 

As part of a continuous effort to increase market share of the health and wellness industry that is growing at an exponential rate, we will also evaluate adding additional products to the ATP Zeta Super Health Program; and considering the potential of the synergies between the health and beauty sectors, we will further involve ourselves in the topical approach of skin and hair regime.

 

Results of Operation

 

For the three months ended September 30, 2019 and 2018

 

Revenue

 

The Company generated revenue of $236,736 for the three months ended September 30, 2019 as compared to $415,367 for the three months ended September 30, 2018. The revenues were mainly derived from the sale of healthy food products.

 

Cost of Revenue

 

Cost of revenue for the three months ended September 30, 2019 amounted to $210,383 as compared to $378,423 for the three months ended September 30, 2018. The costs were predominantly cost of goods and packing materials.

 

Operating Expenses

 

Selling, general and administrative and other operating expenses for the three months ended September 30, 2019 amounted to $144,282. The amount mainly comprised unrealized foreign exchange losses, rental and professional accounting support fees.

 

Selling, general and administrative and other operating expenses for the three months ended September 30, 2018 amounted to $118,618. The amount mainly comprised unrealized foreign exchange losses, professional fees incurred in relation to the procurement of central securities depository services and employees’ recruitment fees paid.

 

Other Income

 

For the three months ended September 30, 2019, the Company recorded an amount of $19,865 as other income. This income was mainly derived from the interest income earned through the time deposits placed with banks.

 

For the three months ended September 30, 2018, the Company recorded an amount of $1,621 as other income. This income was mainly unrealized gain in foreign currencies.

 

Net Loss

 

The Company sustained net loss of $98,064 and $135,866 for the three months ended September 30, 2019 and 2018 respectively. The losses sustained for both the financial period were predominantly due to minimal revenue generated and relatively high unrealized foreign exchange losses.

 

Liquidity and Capital Resources

 

As of September 30, 2019, we had working capital surplus of $3,618,696 consisting of cash on hand of $265,691 and time deposit of $2,487,389 as compared to working capital of $3,720,068 consisting of cash on hand of $353,214 and time deposit of $2,504,373 as of September 30, 2018.

 

4
 

 

Net cash used in operating activities for the three months ended September 30, 2019 was $107,765 as compared to net cash provided by operating activities of $307,005 for the three months ended September 30, 2018. The cash used in operating activities were mainly to fund accounts receivables.

 

There were no investing activities nor financing activities for the three months ended September 30, 2019 and 2018.

 

The revenues, generated from our current business operations alone may not be sufficient to fund our operations or planned growth. We will likely require additional capital to continue to operate our business, and to further expand our business. Sources of additional capital through various financing transactions or arrangements with third parties may include equity or debt financing, bank loans or revolving credit facilities. We may not be successful in locating suitable financing transactions in the time period required or at all, and we may not obtain the capital we require by other means. Our inability to raise additional funds when required may have a negative impact on our operations, business development and financial results.

 

Credit Facilities

 

We do not have any credit facilities or other access to bank credit.

 

Off-Balance Sheet Arrangements

 

As of September 30, 2019, we have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our stockholders.

 

Recent accounting pronouncements

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:

 

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605)”, and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. In August 2015, the FASB issued an Accounting Standards Update to defer by one year the effective dates of its new revenue recognition standard until annual reporting periods beginning after December 15, 2017 (2018 for calendar-year public entities) and interim periods therein. Management is currently assessing the impact of the adoption of ASU 2014-09 and has not determined the effect of the standard on our ongoing financial reporting.

 

In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. The Company is evaluating this ASU and has not determined the effect of this standard on its ongoing financial reporting.

 

5
 

 

In September 2017, the FASB has issued ASU No. 2017-13, Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.” The amendments in ASU No. 2017-13 amends the early adoption date option for certain companies related to theadoption of ASU No. 2014-09 and ASU No. 2016-02. Both of the below entities may still adopt using the public company adoption guidance in the related ASUs, as amended. The effective date is the same as the effective date and transition requirements for the amendments for ASU 2014-09 and ASU 2016-02.

 

In January 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business”, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This amendment was effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU No. 2017-01 did not have a material impact on the Company’s financial position, results of operations and liquidity.

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

 

ITEM 3 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Foreign exchange risk. Substantially most of our revenues and most of our expenses are denominated in Ringgit. We do not believe that we currently have any significant direct foreign exchange risk and have not hedged exposures denominated in foreign currencies or any other derivative financial instruments. Although in general, our exposure to foreign exchange risks should be limited, the value of an investment in our Common Stock may be affected by the foreign exchange rate between U.S. dollar and Ringgit because the value of our business is effectively denominated in Ringgit, while the Common Stock is traded in U.S. dollars.

 

Credit risk. Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

 

ITEM 4 CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

Disclosures Control and Procedures

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) or 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, the company’s principal executive and principal financial officers and effected by the company’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America and includes those policies and procedures that:

 

  Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the company;
     
  Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and
     
  Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements.

 

6
 

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Because of the inherent limitations of internal control, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

 

As of September 30, 2019, management assessed the effectiveness of our internal control over financial reporting based on the criteria for effective internal control over financial reporting established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) and SEC guidance on conducting such assessments. Based on such evaluation, the Company’s management concluded that, during the period covered by this Report, internal controls and procedures over financial reporting were not effective. This was due to deficiencies that existed in the design or operation of our internal controls over financial reporting that adversely affected our internal controls and that may be considered to be material weaknesses.

 

Identified Material Weakness

 

A material weakness in internal control over financial reporting is a control deficiency, or combination of control deficiencies, that results in more than a remote likelihood that a material misstatement of the financial statements will not be prevented or detected.

 

Management identified the following material weakness during its assessment of internal controls over financial reporting as of September 30, 2019. We do not have adequate segregation of duties and effective risk assessment. Lack of segregation of duties and effective risk assessment may cause the Company to face the likelihood of fraud or theft, due to poor oversight, governance and review to detect errors.

 

Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the company’s internal controls.

 

As a result of the material weaknesses described above, management has concluded that the Company did not maintain effective internal control over financial reporting as of September 30, 2019 based on criteria established in Internal Control—Integrated Framework issued by COSO.

 

Management’s Remediation Initiatives

 

In an effort to remediate the identified material weaknesses and other deficiencies and enhance our internal controls, we have, during the fiscal year 2019, prepared written policies and procedures for accounting and financial reporting with respect to the requirements and application of both US GAAP and SEC guidelines, to establish a formal process to close our books monthly on an accrual basis and account for all transactions, including equity and debt transactions.

 

We plan to initiate the following series of measures to further strengthen the Company’s internal controls going forward:

 

1. We plan to create a position to segregate duties consistent with control objectives and will increase our personnel resources and technical accounting expertise within the accounting function. The accounting personnel is responsible for reviewing the financing activities, facilitate the approval of the financing, record the information regarding the financing, and submit SEC filing related documents to our legal counsel in order to comply with the filing requirements of SEC.
   
2. We intend to add staff members to our management team for making sure that information required to be disclosed in our reports filed and submitted under the Exchange Act is recorded, processed, summarized and reported as and when required and the staff members will have segregated responsibilities with regard to these responsibilities.

 

We anticipate that these initiatives will be at least partially, if not fully, implemented by the end of fiscal year 2020.

 

7
 

 

Changes in internal controls over financial reporting

 

There were no significant changes in our internal controls over financial reporting that occurred during the period covered by this Report, which has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting:

 

This interim report does not include an attestation report of the Company’s registered independent public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered independent public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this Quarterly Report on Form 10-Q.

 

PART II — OTHER INFORMATION

 

Item 1. Legal Proceedings

 

We know of no materials, active or pending legal proceedings against us, nor are we involved as a plaintiff in any material proceedings or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any beneficial shareholder are an adverse party or has a material interest averse to us.

 

Item 1A. Risk Factors.

 

Risks Related to our Business

 

We are exposed to concentration risk of heavy reliance on our major customer. A loss of our major customer may significantly impact on our business and results of operation.

 

For the year ended June 30, 2019, we earned revenue of $236,736 from our major customer. Our major customer may terminate its business relationships with us at any time. We cannot assure you that our major customer will maintain current business relationship with us. If it chooses not to do so, our business, financial condition and operating results may suffer from a material adverse impact.

 

We are exposed to concentration risk of heavy reliance on our major supplier for the supply of our products, and any shortage of, or delay in, the supply may significantly impact on our business and results of operation.

 

For the year ended June 30, 2019, we purchased $210,383 from our major supplier. Our business, financial condition and operating results depend on the continuous supply of products from our major supplier and our continuous supplier-customer relationship with it. Our heavy reliance on our major supplier for the supply of our products will have significant impact on our business and results of operation in the event of any shortage of, or delay in the supply.

 

Our major supplier may terminate the distribution agreement by giving notice to us, in which case our business, financial condition and operating results may suffer from a material adverse impact.

 

As is customary in distribution arrangements of this type, the distribution agreement with our major supplier is terminable by either party by giving notice. There is no assurance that our major supplier will not terminate the distribution agreement. In the event that it terminates the distribution agreement, we will have to source products from other suppliers and we may not be able to secure supply of products with quantity and quality required to support our business or at all. Such termination may therefore have a material adverse impact on our business, financial condition and operating results if we fail to engage any other suppliers before the termination.

 

8
 

 

We are exposed to unforeseeable events of labor disputes, strike action or natural disasters or other accidents which may affect the supply of our products from our major supplier.

 

There is no assurance that our major supplier will continue to supply its products in the quantities and timeframes required by us to meet the needs of our customers or comply with its supply agreement with us. Our product supply may also be disrupted by potential labor disputes, strike action or natural disasters or other accidents affecting the supplier. If our supplier does not supply products to us in a timely manner or in sufficient quantities, our business, financial condition and operating results may be materially and adversely affected. Furthermore, in the event of any delay in delivery of the products to us, our cashflow or working capital may be materially and adversely affected as a result of the corresponding delay in delivery of our products to our customers, and hence the delay in our receipt of payment from our customers.

 

Our major supplier may change its existing sales or marketing strategy by changing its export strategy, reducing its sales or production volume, changing its selling prices or appointing other distributors which may compete with us in the market where we currently operate or which we plan to expand into.

 

Our major supplier may change its existing sales or marketing strategy in respect of the products supplied to us by changing its export strategy, reducing its sales or production volume or changing its selling prices. Consequently, there is no assurance that our major supplier will not appoint other dealers or distributors which may compete with us in the market where we operate. Furthermore, any significant increase in the selling prices of the products which we source from our supplier will increase our costs and may adversely affect our profit margin if we are not able to pass the increased costs on to our customers.

 

There is no assurance that there will be no deterioration in our relationship with our major supplier which could affect our ability to secure sufficient supply of products for our business. In the event that our major supplier changes its sales or marketing strategy or otherwise appoint other dealers or distributors who may compete with us, our business, financial condition and operating results may be materially and adversely affected.

 

We could be adversely affected by a change in consumer preferences, perception and spending habits and failure to develop or enrich our product offering or gain market acceptance of our new products could have a negative effect on our business.

 

The market we operate is subject to changes in consumer preference, perception and spending habits. Our performance depends significantly on factors which may affect the level and pattern of consumer spending in the market we operate. Such factors include consumer preference, consumer confidence, consumer income and consumer perception of the safety and quality of our products. Media coverage regarding the safety or quality of, or diet or health issues relating to, our products or the raw materials, ingredients or processes involved in their manufacturing, may damage consumer confidence in our products. A general decline in the consumption of our products could occur as a result of change in consumer preference, perception and spending habits at any time.

 

Any failure to adapt our product offering to respond to such changes may result in a decrease in our sales if such changes are related to certain of our products. Any changes in consumer preference could result in lower sales of our products, put pressure on pricing or lead to increased levels of selling and promotional expenses. In any event a decrease in customer demand on our products may also result in lower sales and slow down the consumption of our inventory to a low inventory turnover level. Any of these changes could result in a material adverse effect on our business, financial conditions or results of operations.

 

9
 

 

The success of our products depends on a number of factors including our ability to accurately anticipate changes in market demand and consumer preferences, our ability to differentiate the quality of our products from those of our competitors, and the effectiveness of our marketing and advertising campaigns for our products. We may not be successful in identifying trends in consumer preferences and developing products that respond to such trends in a timely manner. We also may not be able to effectively promote our products by our marketing and advertising campaigns and gain market acceptance. If our products fail to gain market acceptance, are restricted by regulatory requirements, or have quality problems, we may not be able to fully recover our costs and expenses incurred in our operation, and our business prospects, financial condition or results of operations may be materially and adversely affected.

 

We may incur losses resulting from product liability claims or product recalls.

 

We may incur losses resulting from product liability claims with respect to our products supplied by our supplier. We may face claims or liabilities which may arise if there exist any defects in quality of these products or any of these products are deemed or proven to be unsafe, defective or contaminated. In the event that the use or misuse of any product distributed by us results in personal injury or death, product liability and/or indemnity claims may be brought against us, in addition to our product recalls, and the relevant regulatory authorities in the market we operate may close down some of our related operations and take administrative actions against us. If we experience any business disruption and litigation, we may incur additional costs and have to divert our management’s attention and resources on such matters, which may adversely affect our business, financial condition and results of operations.

 

We operate in a heavily regulated industry.

 

Our business is principally regulated by various laws and regulations in the market we operate, such as in Malaysia the Food Act of 1983 and Food Regulation 1985 mandate authorization from the Food and Quality Division of the Ministry of Health for our Company’s products to be sold in the country.

 

Various registrations, certificates and/or licenses for the conduct of our business are required under the above laws, which also contain provisions for requirements on the storage, labelling, advertising and importation of some of our products.

 

Based on our experience, some of the laws and regulations of the place where we operate our business are subject to amendments, uncertainty in interpretation and administrative actions from time to time. Therefore, we cannot assure you that, for the implementation of our business plans and the introduction of any new product, we will be able to obtain all the necessary registrations, certificates and/or licenses. Any failure to comply with the above laws and regulations may give rise to fines, administrative penalties and/or prosecution against us, which may adversely affect our reputation, financial condition or results of operation.

 

Legal disputes or proceedings could expose us to liability, divert our management’s attention and negatively impact our reputation.

 

We may at times be involved in potential legal disputes or proceedings during the ordinary course of business operations relating to product or other types of liability, employees’ claims, labor disputes or contract disputes that could have a material and adverse effect on our reputation, operation and financial condition. If we become involved in material or protracted legal proceedings or other legal disputes in the future, the outcome of such proceedings could be uncertain and could result in settlements or outcomes which adversely affect our financial condition. In addition, any litigation or legal proceedings could incur substantial legal expenses as well as significant time and attention of our management, diverting their attention from our business and operations.

 

10
 

 

If we are not successful in our innovation activities, our results may be negatively affected.

 

Achieving our business growth objectives depends in part on our ability to successfully develop, introduce and market new products. The success of our innovation activities in turn depends on our ability to correctly anticipate customer and consumer acceptance and trends, obtain, maintain and enforce necessary intellectual property protections and avoid infringing on the intellectual property rights of others. If we are not successful in our innovation activities, we may not be able to achieve our growth objectives, which may have a negative impact on our financial results.

 

Fluctuations in foreign currency exchange rates could have a material adverse effect on our financial results.

 

We earn revenues, pay expenses, own assets and incur liabilities in countries using currencies other than the U.S. dollar, including Malaysian Ringgit. Because our consolidated financial statements are presented in U.S. dollars, we must translate revenues, income and expenses, as well as assets and liabilities, into U.S. dollars at exchange rates in effect during or at the end of each reporting period. Therefore, increases or decreases in the value of the U.S. dollar against other currencies affect our net operating revenues, operating income and the value of balance sheet items denominated in foreign currencies. We cannot assure you that fluctuations in foreign currency exchange rates, particularly the strengthening of the U.S. dollar against major currencies would not materially affect our financial results.

 

Our business depends on the continued contributions made by Mr. How Kok Choong, as our key executive officer, the loss of who may result in a severe impediment to our business.

 

Our success is dependent upon the continued contributions made by our CEO and President, Mr. How Kok Choong. We rely on his expertise in business operations when we are developing our business. We have no “Key Man” insurance to cover the resulting losses in the event that any of our officer or directors should die or resign.

 

If Mr. How Kok Choong cannot serve the Company or is no longer willing to do so, the Company may not be able to find alternatives in a timely manner or at all. This would likely result in a severe damage to our business operations and would have an adverse material impact on our financial position and operating results. To continue as a viable operation, the Company may have to recruit and train replacement personnel at a higher cost.

 

Additionally, if Mr. How Kok Choong joins our competitors or develops similar businesses that are in competition with our Company, our business may also be negatively impacted.

 

Our future success depends on our ability to attract and retain qualified long-term staff to fill management, technology, sales, marketing, and customer services positions. We have a great need for qualified talent, but we may not be successful in attracting, hiring, developing, and retaining the talent required for our success.

 

If we are not able to achieve our overall long-term growth objectives, the value of an investment in our Company could be negatively affected.

 

We have established and publicly announced certain long-term growth objectives. These objectives were based on, among other things, our evaluation of our growth prospects, which are generally driven by the sales potential of many product types, some of which are more profitable than others, and on an assessment of the potential price and product mix. There can be no assurance that we will realize the sales potential and the price and product mix necessary to achieve our long-term growth objectives.

 

11
 

 

Risks Related to our Industry

 

Our business and reputation may be affected by product liability claims, litigation, customer complaints, product tampering, food safety issues, food-borne illnesses, health threats, quality control concerns or adverse publicity relating to our products. Product liability insurance of our supplier may not cover our liability sufficiently or at all.

 

Like other consumer product manufacturers, sale of our products involves an inherent risk of our products being found to be unfit for consumption or cause illness. Products may be rendered unfit for consumption due to raw materials or product contamination or degeneration, presence of microbials, illegal tampering of products by unauthorized third parties or other problems arising during the various stages of the procurement, production, transportation and storage processes. The occurrence of such problems may result in customer complaints, fines, penalties or adverse publicity causing serious damage to our reputation and brand, as well as product liability claims, other legal disputes and loss of revenues. Under certain circumstances, we may be required to recall our products. Even if a situation does not necessitate a product recall, we cannot assure you that product liability claims or other legal disputes will not be asserted against us as a result. Product liability insurance of our supplier may not cover our liability sufficiently or at all and will not cover liability that arises out of our default such as mishandling, poor storage condition and/or contamination of the products by us. As a result, a product liability or other judgment against us, or a product recall, could have a material adverse effect on our business, financial condition or results of operations.

 

Our business is susceptible to food-borne illnesses. We cannot assure you that we are able to effectively prevent all diseases or illnesses caused by our products or contamination of our products. Furthermore, our reliance on third-party product suppliers means that food-borne illness incidents could be caused by our suppliers outside of our control. New illnesses may develop in the future, or diseases with long incubation periods could arise that could give rise to claims or allegations on a retroactive basis. Reports in the media of instances of food-borne illnesses or health threats of our products or any of their major ingredients could adversely and significantly affect our sales, and have significant negative impact on our results of operations. This risk exists even if it were later determined that the illness or health threat in fact was not caused by our products.

 

In addition, adverse publicity about health and safety concerns, whether unfounded or not, may discourage consumers from buying our products. Even if a product liability claim is unsuccessful or is not fully pursued, the negative publicity surrounding any assertion that our products caused personal injury or illness could adversely affect our reputation and our corporate and brand image. If consumers were to lose confidence in our brand and reputation, we could suffer long-term or even permanent declines in our sales and results of operation. The amount of negative news, customers complaints and claims against us may also be very costly and may divert our management’s attention from our business operation.

 

Increased competition and capabilities in the marketplace could hurt our business.

 

The market where we operate is highly competitive. We compete with other companies that operate in multiple geographic areas, as well as numerous companies that are primarily regional or local in operation. Our ability to gain or maintain share of sales in the market where we operate or in various local markets may be limited as a result of actions by competitors. If we do not continue to strengthen our capabilities in marketing and innovation to maintain our brand loyalty and market share while we selectively expand into other product categories, our business could be negatively affected.

 

12
 

 

Risks Related to our Common Stock

 

The market price of our shares is likely to be highly volatile and subject to wide fluctuations in response to factors such as:

 

variations in our actual and perceived operating results;
   
news regarding gains or losses of customers or suppliers by us or our competitors;
   
news regarding gains or losses of key personnel by us or our competitors;
   
announcements of competitive developments, acquisitions or strategic alliances in our industry by us or our competitors;
   
changes in earnings estimates or buy/sell recommendations by financial analysts;
   
potential litigation;
   
the imposition of fines or penalties related to our activities in the market where we operate and failure to comply with applicable rules and regulations;
   
general market conditions or other developments affecting us or our industry; and
   
the operating and stock price performance of other companies, other industries and other events or factors beyond our control.

 

In addition, the securities markets have from time to time experienced significant price and volume fluctuations that are not related to the operating performance of particular companies. These market fluctuations may also materially and adversely affect the market price of the shares.

 

We may never be able to pay dividends and are unlikely to do so.

 

To date, we have not paid, nor do we intend to pay in the foreseeable future, dividends on our common stock, even if we become profitable. Earnings, if any, are expected to be used to advance our activities and for working capital and general corporate purposes, rather than to make distributions to stockholders. Since we are not in a financial position to pay dividends on our common stock and future dividends are not presently being contemplated, investors are advised that return on investment in our common stock is restricted to an appreciation in the share price. The potential or likelihood of an increase in share price is uncertain.

 

In addition, under Nevada law, we may only pay dividends subject to our ability to service our debts as they become due and provided that our assets will exceed our liabilities after the dividend. Our ability to pay dividends will therefore depend on our ability to generate sufficient profits.

 

13
 

 

Shareholders may be diluted significantly through our efforts to obtain financing and satisfy obligations through the issuance of securities.

 

Wherever possible, our board of directors will attempt to use non-cash consideration to satisfy obligations. In many instances, we believe that the non-cash consideration will consist of shares of our common stock, warrants to purchase shares of our common stock or other securities. Our board of directors has authority, without action or vote of the shareholders, to issue all or part of the authorized but unissued shares of common stock or warrants to purchase such shares of common stock. In addition, we may attempt to raise capital by selling shares of our common stock, possibly at a discount to market in the future. These actions will result in dilution of the ownership interests of existing shareholders and may further dilute common stock book value, and that dilution may be material. Such issuances may also serve to enhance existing management’s ability to maintain control of us, because the shares may be issued to parties or entities committed to supporting existing management

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information.

 

None

 

14
 

 

ITEM 6. Exhibits

 

Exhibit No.   Description
     
31.1   Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer and principal financial officer*
     
32.1   Section 1350 Certification of principal executive officer and principal financial officer*
     
101.INS   XBRL Instance Document*
     
101.SCH   XBRL Schema Document*
     
101.CAL   XBRL Calculation Linkbase Document*
     
101.DEF   XBRL Definition Linkbase Document*
     
101.LAB   XBRL Label Linkbase Document*
     
101.PRE   XBRL Presentation Linkbase Document*

 

* Filed herewith.

 

15
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  AGAPE ATP CORPORATION
  (Name of Registrant)
   
Date: November 8, 2019  
  By: /s/ How Kok Choong
  Title:

Chief Executive Officer,
President, Director, Secretary and Treasurer

    (Principal Executive Officer and Principal Financial Officer)

 

16
 

EX-31.1 2 ex31-1.htm

 

EXHIBIT 31.1

 

CERTIFICATION

 

I, HOW KOK CHOONG, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Agape ATP Corporation (the “Company”) for the quarter ended September 30, 2019;

 

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 8, 2019 By: /s/ How Kok Choong
    HOW KOK CHOONG
   

Chief Executive Officer,
President, Director, Secretary, Treasurer

    (Principal Executive Officer and Principal Financial Officer)

 

 
 

EX-32.1 3 ex32-1.htm

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Agape ATP Corporation (the “Company”) on Form 10-Q for the quarter ended September 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), The undersigned hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: November 8, 2019 By: /s/ How Kok Choong
    HOW KOK CHOONG
    Chief Executive Officer, President, Director
    (Principal Executive Officer and Principal Financial Officer)

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 
 

EX-101.INS 4 aatp-20190930.xml XBRL INSTANCE FILE 0001713210 2018-06-30 0001713210 country:US 2019-06-30 0001713210 AATP:GreenproCapitalCorpMember 2018-05-17 0001713210 2019-07-01 2019-09-30 0001713210 2019-06-30 0001713210 us-gaap:CommonStockMember 2019-06-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001713210 us-gaap:RetainedEarningsMember 2019-06-30 0001713210 country:HK 2019-06-30 0001713210 AATP:GreenproCapitalCorpMember 2018-10-16 0001713210 AATP:GreenproCapitalCorpMember 2019-06-30 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001713210 AATP:PhoenixPlusCorpMember 2019-04-03 0001713210 AATP:PhoenixPlusCorpMember us-gaap:CommonStockMember 2019-04-03 0001713210 AATP:DirectorsOfUnreservedInvestmentMember 2019-06-30 0001713210 AATP:PhoenixPlusCorpMember 2019-06-30 0001713210 us-gaap:TradeAccountsReceivableMember 2019-06-30 0001713210 2019-11-08 0001713210 2019-09-30 0001713210 2018-07-01 2018-09-30 0001713210 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0001713210 us-gaap:CommonStockMember 2019-09-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0001713210 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001713210 us-gaap:RetainedEarningsMember 2019-09-30 0001713210 2018-09-30 0001713210 AATP:AgapeATPInternationalHoldingLimitedMember 2019-09-30 0001713210 AATP:SubsidiaryCompanyMember 2019-07-01 2019-09-30 0001713210 AATP:SubsidiaryCompanyMember 2019-09-30 0001713210 AATP:SubsidiaryCompanyOneMember 2019-07-01 2019-09-30 0001713210 AATP:SubsidiaryCompanyOneMember 2019-09-30 0001713210 AATP:PeriodEndMYRMember 2019-09-30 0001713210 AATP:PeriodEndMYRMember 2018-09-30 0001713210 AATP:PeriodAverageMYRMember 2019-09-30 0001713210 AATP:PeriodAverageMYRMember 2018-09-30 0001713210 AATP:PeriodEndHKDMember 2019-09-30 0001713210 AATP:PeriodEndHKDMember 2018-09-30 0001713210 AATP:PeriodAverageHKDMember 2019-09-30 0001713210 AATP:PeriodAverageHKDMember 2018-09-30 0001713210 AATP:PeriodendAUDMember 2019-09-30 0001713210 AATP:PeriodendAUDMember 2018-09-30 0001713210 AATP:PeriodAverageAUDMember 2019-09-30 0001713210 AATP:PeriodAverageAUDMember 2018-09-30 0001713210 AATP:MYRCurrencyMember 2019-07-01 2019-09-30 0001713210 AATP:MYRCurrencyMember 2018-07-01 2018-09-30 0001713210 AATP:HKDCurrencyMember 2019-07-01 2019-09-30 0001713210 AATP:HKDCurrencyMember 2018-07-01 2018-09-30 0001713210 AATP:AUDCurrencyMember 2019-07-01 2019-09-30 0001713210 AATP:AUDCurrencyMember 2018-07-01 2018-09-30 0001713210 AATP:GreenproCapitalCorpMember 2019-09-30 0001713210 srt:DirectorMember 2019-09-30 0001713210 srt:DirectorMember AATP:MYRCurrencyMember 2019-09-30 0001713210 srt:MaximumMember 2019-09-30 0001713210 srt:MinimumMember 2019-09-30 0001713210 AATP:DirectorsOfUnreservedInvestmentMember 2019-09-30 0001713210 AATP:PhoenixPlusCorpMember 2019-09-30 0001713210 us-gaap:TradeAccountsReceivableMember 2019-09-30 0001713210 AATP:AgapeSEASdnBhdMember 2019-07-01 2019-09-30 0001713210 AATP:AgapeSEASdnBhdMember 2018-07-01 2018-09-30 0001713210 AATP:AgapeATPAsiaLimitedMember 2019-07-01 2019-09-30 0001713210 AATP:AgapeATPAsiaLimitedMember 2018-07-01 2018-09-30 0001713210 AATP:AgapeSuperiorLivingPtyLtdMember 2019-07-01 2019-09-30 0001713210 AATP:AgapeSuperiorLivingPtyLtdMember 2018-07-01 2018-09-30 0001713210 us-gaap:IPOMember 2019-09-30 0001713210 us-gaap:EmployeeStockOptionMember 2019-07-01 2019-09-30 0001713210 us-gaap:WarrantMember 2019-07-01 2019-09-30 0001713210 AATP:OtherMember 2019-07-01 2019-09-30 0001713210 country:US 2019-09-30 0001713210 country:US 2019-07-01 2019-09-30 0001713210 AATP:LabuanMember 2019-07-01 2019-09-30 0001713210 country:HK 2019-07-01 2019-09-30 0001713210 AATP:LabuanMember 2018-07-01 2018-09-30 0001713210 country:HK 2018-07-01 2018-09-30 0001713210 country:HK 2019-09-30 0001713210 AATP:CustomersMember 2019-07-01 2019-09-30 0001713210 AATP:CustomersMember 2018-07-01 2018-09-30 0001713210 AATP:VendorMember 2019-07-01 2019-09-30 0001713210 AATP:VendorMember 2018-07-01 2018-09-30 0001713210 us-gaap:SalesRevenueNetMember AATP:CustomerAMember 2019-07-01 2019-09-30 0001713210 us-gaap:SalesRevenueNetMember AATP:CustomerAMember 2018-07-01 2018-09-30 0001713210 us-gaap:SalesRevenueNetMember 2019-07-01 2019-09-30 0001713210 us-gaap:SalesRevenueNetMember 2018-07-01 2018-09-30 0001713210 us-gaap:AccountsReceivableMember AATP:CustomerAMember 2019-09-30 0001713210 us-gaap:AccountsReceivableMember AATP:CustomerAMember 2018-09-30 0001713210 us-gaap:CostOfSalesMember AATP:VendorAMember 2019-07-01 2019-09-30 0001713210 us-gaap:CostOfSalesMember AATP:VendorAMember 2018-07-01 2018-09-30 0001713210 us-gaap:CostOfSalesMember AATP:VendorBMember 2018-07-01 2018-09-30 0001713210 us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0001713210 us-gaap:CostOfSalesMember 2018-07-01 2018-09-30 0001713210 us-gaap:AccountsPayableMember AATP:VendorAMember 2019-09-30 0001713210 us-gaap:AccountsPayableMember AATP:VendorAMember 2018-09-30 0001713210 us-gaap:AccountsPayableMember AATP:VendorBMember 2018-09-30 0001713210 country:US 2018-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:MYR Agape ATP Corp 0001713210 10-Q 2019-09-30 false --06-30 Accelerated Filer Q1 2020 376275500 0.0001 0.0001 0.0001 0.0001 200000000 200000000 1000000000 1000000000 2500000 376275500 376275500 2500000 376275500 376275500 2500000 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>10. OTHER PAYABLES AND ACCRUED LIABILITIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2019</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 63%"><font style="font: 10pt Times New Roman, Times, Serif">Accrued audit fees</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,500</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">20,000</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Accrued professional fees</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,417</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Deposit received from customer</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">77,962</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">78,231</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Others</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">36,413</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12,360</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total payables and accrued liabilities</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">123,292</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">110,591</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>12. AMOUNT DUE TO A DIRECTOR</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2019 and June 30, 2019, a director of the Company advanced $3,926 and $3,938 respectively to the Company, which is unsecured, interest-free with no fixed repayment term, for working capital purpose. Imputed interest is considered insignificant.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>8. RELATED PARTY TRANSACTIONS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="14" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended September 30,</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Revenue</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Accounts Receivable, Trade</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%"><font style="font: 10pt Times New Roman, Times, Serif">Agape S.E.A. Sdn Bhd</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">236,736</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">415,367</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">628,583</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">745</font></td> <td style="width: 1%">&#160;</td></tr> <tr> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Expenses paid on behalf</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Accounts Payable, Non-trade</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%"><font style="font: 10pt Times New Roman, Times, Serif">Agape ATP (Asia) Limited</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,204</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;-</font></td> <td style="width: 1%">&#160;</td></tr> <tr> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Sundry Purchases</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Accounts Payable, Non-trade</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%"><font style="font: 10pt Times New Roman, Times, Serif">Agape Superior Living Pty Ltd</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">35,024</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;-</font></td> <td style="width: 1%">&#160;</td></tr> <tr> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="background-color: white"> <td style="vertical-align: bottom; width: 30%"><font style="font: 10pt Times New Roman, Times, Serif"><u>Related parties</u></font></td> <td style="vertical-align: top; width: 1%">&#160;</td> <td style="vertical-align: top; width: 69%"><font style="font: 10pt Times New Roman, Times, Serif"><u>Relationships</u></font></td></tr> <tr style="vertical-align: top; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Agape S.E.A. Sdn Bhd</font></td> <td>&#160;</td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Mr How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape S.E.A. Sdn Bhd</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Agape Superior Living Pty Ltd</font></td> <td>&#160;</td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Mr How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of Agape Superior Living Pty Ltd</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Agape ATP (Asia) Limited</font></td> <td>&#160;</td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Mr How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape ATP (Asia) Limited.</font></td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>14. SUBSEQUENT EVENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC Topic 855, &#8220;<i>Subsequent Events</i>&#8221;, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after September 30, 2019 up through the date the Company issued the audited consolidated financial statements. During this period, there was no subsequent event that required recognition or disclosure.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basis of presentation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;US GAAP&#8221;).</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basis of consolidation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Use of estimates</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue recognition</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In accordance with ASC Topic 605, &#8220;Revenue Recognition&#8221;, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Revenue from supplies of healthy food products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company&#8217;s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management&#8217;s best estimates and historical experience and are provided for in the same period as the related revenues are recorded. Based on limited operating history, management estimates that there was no sale return for the period reported.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cost of revenue</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of revenue includes the purchase cost of manufactured goods for sale to customers It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash and cash equivalents</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Income taxes</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Net loss per share</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company calculates net loss per share in accordance with ASC Topic 260 &#8220;<i>Earnings per share</i>&#8221;. Basic loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Related parties</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Fair value of financial instruments:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of the Company&#8217;s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company also follows the guidance of the ASC Topic 820-10, &#8220;<i>Fair Value Measurements and Disclosures</i>&#8221; (&#8220;ASC 820-10&#8221;), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 1: Observable inputs such as quoted prices in active markets;</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended September 30, 2019 and 2018, the local (United States) and foreign components of loss before income taxes were comprised of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended September 30,</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Tax jurisdictions from:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 63%"><font style="font: 10pt Times New Roman, Times, Serif">- Local</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(86,056</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(21,497</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">- Foreign, representing</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Labuan</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(22,072</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(81,004</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Hong Kong</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10,064</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(29,661</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Loss before income tax</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(98,064</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(132,162</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The provision for income taxes consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended September 30,</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Current:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">- Local</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;-</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 61%; padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">- Foreign</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,704</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Deferred:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">- Local</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">- Foreign</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Income tax expense</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,704</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of September 30, 2019 and June 30, 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of<br /> September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of<br /> June 30, 2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Deferred tax assets:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Net operating loss carry forwards</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 61%; padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">-United States of America</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">110,141</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">92,069</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">-Hong Kong</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less: valuation allowance</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(110,141</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(92,069</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Deferred tax asset</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2019</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 63%"><font style="font: 10pt Times New Roman, Times, Serif">Accrued audit fees</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,500</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">20,000</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Accrued professional fees</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,417</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Deposit received from customer</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">77,962</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">78,231</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Others</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">36,413</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12,360</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total payables and accrued liabilities</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">123,292</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">110,591</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">As of and for the three months<br /> ended September 30,</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 63%"><font style="font: 10pt Times New Roman, Times, Serif">Period-end MYR : US$1 exchange rate</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.19</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.14</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Period-average MYR : US$1 exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.18</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.09</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Period-end HKD : US$1 exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7.84</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7.83</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Period-average HKD : US$1 exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7.84</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7.85</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Period-end AUD : US$1 exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.48</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Period-average AUD : US$1 exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.47</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> 724619 724619 26353 36944 19865 1621 3704 -98064 -135866 -98064 -0.00 -0.00 376275500 376275500 -98064 -80053 -52109 4580353 37628 5293082 -750278 -79 4478981 37628 5293082 -3387 -848342 3938 3926 210383 378423 210383 314423 64000 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>5. CASH AND CASH EQUIVALENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">As at September 30, 2019, the Company recorded $2,753,080 of cash and cash equivalents (June 30,2019: $2,857,587), which consists $265,691 of cash on hand (June 30,2019: $353,214) and $2,487,389 (June 30, 2019: $2,504,373) of time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments. The effective interest rate for the time deposits ranges between 2.95% to 3.25% per annum (September 30,2019: 2.95% to 3.25%).</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>7. PREPAYMENTS AND DEPOSITS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2019</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 63%"><font style="font: 10pt Times New Roman, Times, Serif">Prepaid expenses</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12,420</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">21,081</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Deposits to supplier</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">349,629</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">477,254</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total prepaid expenses and deposits</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">362,049</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">498,335</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of<br /> September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of<br /> June 30, 2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 63%"><font style="font: 10pt Times New Roman, Times, Serif">Cost of investment</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">501,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">501,000</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less: Impairment in cost of investment</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(366,834</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(366,834</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Investment in marketable securities</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">134,166</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">134,166</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Investment in marketable securities</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Marketable securities included in marketable securities (current) and other investments (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities included in marketable securities (current) are stated at the lower of cost or market in the aggregate. and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><u>Selling, general, administrative and operating expenses</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Selling, general, administrative and operating expenses are primarily comprised of rental of office premises, licensing and professional fees.</p> <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2019</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 63%"><font style="font: 10pt Times New Roman, Times, Serif">Prepaid expenses</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12,420</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">21,081</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Deposits to supplier</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">349,629</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">477,254</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total prepaid expenses and deposits</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">362,049</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">498,335</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Details of the Company&#8217;s subsidiaries:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Subsidiary<br /> company name</b></font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Place and date of<br /> incorporation</b></font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Particulars of<br /> issued capital</b></font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Principal<br /> activities</b></font></td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Proportional of<br /> ownership interest<br /> and voting power held</b></font></td> <td>&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">1.</font></td> <td style="vertical-align: top; width: 2%">&#160;</td> <td style="vertical-align: top; width: 21%"><font style="font: 10pt Times New Roman, Times, Serif">Agape ATP Corporation</font></td> <td style="vertical-align: top; width: 2%">&#160;</td> <td style="vertical-align: top; width: 17%"><font style="font: 10pt Times New Roman, Times, Serif">Labuan,<br /> March 6, 2017</font></td> <td style="vertical-align: top; width: 2%">&#160;</td> <td style="vertical-align: top; width: 17%"><font style="font: 10pt Times New Roman, Times, Serif">100 shares of ordinary share of US$1 each</font></td> <td style="vertical-align: bottom; width: 1%">&#160;</td> <td style="vertical-align: bottom; width: 16%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Investment holding</font></td> <td style="vertical-align: bottom; width: 1%">&#160;</td> <td style="vertical-align: bottom; width: 1%">&#160;</td> <td style="vertical-align: bottom; width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td style="vertical-align: bottom; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">2.</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">Agape ATP International Holding Limited</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">Hong Kong,<br /> June 1, 2017</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000 shares of ordinary share of HK$1 each</font></td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">Health and wellness products and health solution advisory services</font></td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> 6 0.03 0.0001 35145 47641 47641 144282 118618 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Foreign currencies translation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The reporting currency of the Company is United States Dollars (&#8220;US$&#8221;) and the accompanying financial statements have been expressed in US$. The Company&#8217;s subsidiary in Labuan maintains its books and record in United States Dollars (&#8220;US$&#8221;) albeit its functional currency being the primary currency of the economic environment in which the entity operates is the Malaysian Ringgit (&#8220;MYR&#8221;). The Company&#8217;s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (&#8220;HK$&#8221;), similar to itss functional currency.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, &#8220;<i>Translation of Financial Statement&#8221;</i>, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders&#8217; equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">As of and for the three months<br /> ended September 30,</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 63%"><font style="font: 10pt Times New Roman, Times, Serif">Period-end MYR : US$1 exchange rate</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.19</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.14</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Period-average MYR : US$1 exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.18</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.09</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Period-end HKD : US$1 exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7.84</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7.83</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Period-average HKD : US$1 exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7.84</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7.85</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Period-end AUD : US$1 exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.48</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Period-average AUD : US$1 exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.47</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> 134166 134166 134166 134166 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts receivable</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on demand. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer&#8217;s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>3. INVESTMENT IN MARKETABLE SECURITIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">(i)</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On May 17, 2018, the Company purchased common stocks in Greenpro Capital Corp. for $500,000 at purchase price of $6 per share.</font></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">(ii)</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On October 16, 2018, the Company purchased common stocks in Greenpro Capital Corp. for $1,000 at purchase price of $0.03 per share.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of<br /> September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of<br /> June 30, 2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 63%"><font style="font: 10pt Times New Roman, Times, Serif">Cost of investment</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">501,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">501,000</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less: Impairment in cost of investment</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(366,834</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(366,834</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Investment in marketable securities</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">134,166</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">134,166</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> false false false -98064 -132162 -3308 3531255 2857587 2753080 3838260 376275600 376275600 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>1. ORGANIZATION AND BUSINESS BACKGROUND</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Agape ATP Corporation, a Nevada corporation (&#8220;the Company&#8221;) was incorporated under the laws of the State of Nevada on June 1, 2016.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Agape ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company and its subsidiaries are involved in the health and wellness industry. The principal activity of the Company and its subsidiaries is to supply high-quality health and wellness products, including supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in our body.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Details of the Company&#8217;s subsidiaries:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Subsidiary<br /> company name</b></font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Place and date of<br /> incorporation</b></font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Particulars of<br /> issued capital</b></font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Principal<br /> activities</b></font></td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Proportional of<br /> ownership interest<br /> and voting power held</b></font></td> <td>&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">1.</font></td> <td style="vertical-align: top; width: 2%">&#160;</td> <td style="vertical-align: top; width: 21%"><font style="font: 10pt Times New Roman, Times, Serif">Agape ATP Corporation</font></td> <td style="vertical-align: top; width: 2%">&#160;</td> <td style="vertical-align: top; width: 17%"><font style="font: 10pt Times New Roman, Times, Serif">Labuan,<br /> March 6, 2017</font></td> <td style="vertical-align: top; width: 2%">&#160;</td> <td style="vertical-align: top; width: 17%"><font style="font: 10pt Times New Roman, Times, Serif">100 shares of ordinary share of US$1 each</font></td> <td style="vertical-align: bottom; width: 1%">&#160;</td> <td style="vertical-align: bottom; width: 16%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Investment holding</font></td> <td style="vertical-align: bottom; width: 1%">&#160;</td> <td style="vertical-align: bottom; width: 1%">&#160;</td> <td style="vertical-align: bottom; width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td style="vertical-align: bottom; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">2.</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">Agape ATP International Holding Limited</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">Hong Kong,<br /> June 1, 2017</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000 shares of ordinary share of HK$1 each</font></td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">Health and wellness products and health solution advisory services</font></td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Business Overview</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Agape ATP Corporation is a company that develops and provides health solution advisory services to our clients. We primarily focus our efforts on attracting customers in Malaysia. Our advisory services center on the &#8220;ATP Zeta Health Program&#8221;, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At its core, the ATP Zeta Super Health Program is focused upon biological energy, Adenosine Triphosphate (ATP), at the cellular level. The stimulation of ATP production at the cellular level can increase the metabolism and service to promote and maintain normal and healthy functioning of the body&#8217;s systems. As a strong advocator of &#8220;beauty from within&#8221;, our program shall emphasize nutrient absorption through the membrane ion channel to provide complete and balanced nutrients to improve cell health. Thus, ATP Zeta Super Health Program provides ionized and high zeta potential (high bioavailability) nutrients to enhance the absorption at the cellular level.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The ATP Zeta Super Health Program consists of ten products. None of these products are owned or produced by Agape ATP Corporation. In the event that any of these products are no longer produced, or are otherwise unavailable, we may have to devote significant effort to identifying and obtaining comparable replacement products. The ten products that comprise the ATP Zeta Super Health Program are ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, ATP5 BetaMaxx, AGN-Vege Fruit Fiber, AGP1-Iron, YFA-Young Formula, Mitogize and ORYC-Organic Youth Care Cleansing Bar.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At present, our products are mainly sold in Malaysia, and due to the contents and combination of the main ingredients in the products they are categorized as health food rather than medicines or drugs. As such, all products require authorization from the Food and Quality Division of Ministry of Health according to the Food Act of 1983 and Food Regulation 1985 in order to be sold in the country. All of the products in the ATP Zeta Super Health Program have obtained the appropriate authorizations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As part of a continuous effort to increase market share of the health and wellness industry that is growing at an exponential rate, we will also evaluate adding additional products to the ATP Zeta Super Health Program; and considering the potential of the synergies between the health and beauty sectors, we will further involve ourselves in the topical approach of skin and hair regime.</p> -101372 -135866 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying consolidated financial statements and notes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basis of presentation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;US GAAP&#8221;).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basis of consolidation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Use of estimates</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Investment in investee company</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates investment in investee company as it holds an equity interest based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Investment in marketable securities</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Marketable securities included in marketable securities (current) and other investments (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities included in marketable securities (current) are stated at the lower of cost or market in the aggregate. and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Investment in non-marketable securities</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Investments in non-marketable equity securities (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash and cash equivalents</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts receivable</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on demand. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer&#8217;s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue recognition</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In accordance with ASC Topic 605, &#8220;Revenue Recognition&#8221;, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Revenue from supplies of healthy food products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company&#8217;s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management&#8217;s best estimates and historical experience and are provided for in the same period as the related revenues are recorded. Based on limited operating history, management estimates that there was no sale return for the period reported.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cost of revenue</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of revenue includes the purchase cost of manufactured goods for sale to customers It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><u>Selling, general, administrative and operating expenses</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Selling, general, administrative and operating expenses are primarily comprised of rental of office premises, licensing and professional fees.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Income taxes</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Net loss per share</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company calculates net loss per share in accordance with ASC Topic 260 &#8220;<i>Earnings per share</i>&#8221;. Basic loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Foreign currencies translation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The reporting currency of the Company is United States Dollars (&#8220;US$&#8221;) and the accompanying financial statements have been expressed in US$. The Company&#8217;s subsidiary in Labuan maintains its books and record in United States Dollars (&#8220;US$&#8221;) albeit its functional currency being the primary currency of the economic environment in which the entity operates is the Malaysian Ringgit (&#8220;MYR&#8221;). The Company&#8217;s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (&#8220;HK$&#8221;), similar to itss functional currency.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, &#8220;<i>Translation of Financial Statement&#8221;</i>, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders&#8217; equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">As of and for the three months<br /> ended September 30,</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 63%"><font style="font: 10pt Times New Roman, Times, Serif">Period-end MYR : US$1 exchange rate</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.19</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.14</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Period-average MYR : US$1 exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.18</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.09</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Period-end HKD : US$1 exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7.84</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7.83</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Period-average HKD : US$1 exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7.84</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7.85</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Period-end AUD : US$1 exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.48</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Period-average AUD : US$1 exchange rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.47</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Related parties</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Fair value of financial instruments:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of the Company&#8217;s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company also follows the guidance of the ASC Topic 820-10, &#8220;<i>Fair Value Measurements and Disclosures</i>&#8221; (&#8220;ASC 820-10&#8221;), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 1: Observable inputs such as quoted prices in active markets;</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recent accounting pronouncements</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, the FASB issued Accounting Standards Update No. 2014-09, &#8220;Revenue from Contracts with Customers&#8221; (&#8220;ASU 2014-09&#8221;). ASU 2014-09 supersedes the revenue recognition requirements in &#8220;Revenue Recognition (Topic 605)&#8221;, and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. In August 2015, the FASB issued an Accounting Standards Update to defer by one year the effective dates of its new revenue recognition standard until annual reporting periods beginning after December 15, 2017 (2018 for calendar-year public entities) and interim periods therein. Management is currently assessing the impact of the adoption of ASU 2014-09 and has not determined the effect of the standard on our ongoing financial reporting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee&#8217;s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee&#8217;s right to use, or control the use of, a specified asset for the lease term. The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. The Company is evaluating this ASU and has not determined the effect of this standard on its ongoing financial reporting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In January 2017, the FASB issued ASU No. 2017-01, &#8220;Business Combinations (Topic 805): Clarifying the Definition of a Business&#8221;, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This amendment was effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU No. 2017-01 did not have a material impact on the Company&#8217;s financial position, results of operations and liquidity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In September 2017, the FASB has issued ASU No. 2017-13,&#160;<i>Revenue Recognition&#160;</i>(Topic 605),&#160;<i>Revenue from Contracts with Customers&#160;</i>(Topic 606),&#160;<i>Leases&#160;</i>(Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.&#8221; The amendments in ASU No. 2017-13 amends the early adoption date option for certain companies related to the adoption of ASU No. 2014-09 and ASU No. 2016-02. Both of the below entities may still adopt using the public company adoption guidance in the related ASUs, as amended. The effective date is the same as the effective date and transition requirements for the amendments for ASU 2014-09 and ASU 2016-02.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In February 2018, the FASB has issued ASU No. 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220), which allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act. Consequently, the amendments eliminate the stranded tax effects resulting from the Tax Cuts and Jobs Act and will improve the usefulness of information in financial statement. The amendments in this ASU are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. The Company has analyzed the consequences of such adoption and has not determined the effect of this standard on its ongoing financial reporting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In August 2018, the FASB has issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements of Fair Value Measurement. This amendment modifies the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, based on the concepts in the Concepts Statement, including the consideration of costs and benefits, with the primary purpose to improve the effectiveness of disclosures in the notes to financial statements by facilitating clear communication of the information required by US GAAP. The amendments in this update are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recent accounting pronouncements</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, the FASB issued Accounting Standards Update No. 2014-09, &#8220;Revenue from Contracts with Customers&#8221; (&#8220;ASU 2014-09&#8221;). ASU 2014-09 supersedes the revenue recognition requirements in &#8220;Revenue Recognition (Topic 605)&#8221;, and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. In August 2015, the FASB issued an Accounting Standards Update to defer by one year the effective dates of its new revenue recognition standard until annual reporting periods beginning after December 15, 2017 (2018 for calendar-year public entities) and interim periods therein. Management is currently assessing the impact of the adoption of ASU 2014-09 and has not determined the effect of the standard on our ongoing financial reporting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee&#8217;s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee&#8217;s right to use, or control the use of, a specified asset for the lease term. The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. The Company is evaluating this ASU and has not determined the effect of this standard on its ongoing financial reporting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In January 2017, the FASB issued ASU No. 2017-01, &#8220;Business Combinations (Topic 805): Clarifying the Definition of a Business&#8221;, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This amendment was effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU No. 2017-01 did not have a material impact on the Company&#8217;s financial position, results of operations and liquidity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In September 2017, the FASB has issued ASU No. 2017-13,&#160;<i>Revenue Recognition&#160;</i>(Topic 605),&#160;<i>Revenue from Contracts with Customers&#160;</i>(Topic 606),&#160;<i>Leases&#160;</i>(Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.&#8221; The amendments in ASU No. 2017-13 amends the early adoption date option for certain companies related to the adoption of ASU No. 2014-09 and ASU No. 2016-02. Both of the below entities may still adopt using the public company adoption guidance in the related ASUs, as amended. The effective date is the same as the effective date and transition requirements for the amendments for ASU 2014-09 and ASU 2016-02.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In February 2018, the FASB has issued ASU No. 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220), which allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act. Consequently, the amendments eliminate the stranded tax effects resulting from the Tax Cuts and Jobs Act and will improve the usefulness of information in financial statement. The amendments in this ASU are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. The Company has analyzed the consequences of such adoption and has not determined the effect of this standard on its ongoing financial reporting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In August 2018, the FASB has issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements of Fair Value Measurement. This amendment modifies the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, based on the concepts in the Concepts Statement, including the consideration of costs and benefits, with the primary purpose to improve the effectiveness of disclosures in the notes to financial statements by facilitating clear communication of the information required by US GAAP. The amendments in this update are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.</p> <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="14" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended September 30,</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Revenue</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Accounts Receivable, Trade</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%"><font style="font: 10pt Times New Roman, Times, Serif">Agape S.E.A. Sdn Bhd</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">236,736</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">415,367</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">628,583</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">745</font></td> <td style="width: 1%">&#160;</td></tr> <tr> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Expenses paid on behalf</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Accounts Payable, Non-trade</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%"><font style="font: 10pt Times New Roman, Times, Serif">Agape ATP (Asia) Limited</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,204</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;-</font></td> <td style="width: 1%">&#160;</td></tr> <tr> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Sundry Purchases</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Accounts Payable, Non-trade</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%"><font style="font: 10pt Times New Roman, Times, Serif">Agape Superior Living Pty Ltd</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">35,024</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;-</font></td> <td style="width: 1%">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>11. INCOME TAXES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended September 30, 2019 and 2018, the local (United States) and foreign components of loss before income taxes were comprised of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended September 30,</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Tax jurisdictions from:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 63%"><font style="font: 10pt Times New Roman, Times, Serif">- Local</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(86,056</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(21,497</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">- Foreign, representing</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Labuan</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(22,072</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(81,004</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Hong Kong</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10,064</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(29,661</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Loss before income tax</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(98,064</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(132,162</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The provision for income taxes consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended September 30,</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Current:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">- Local</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;-</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 61%; padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">- Foreign</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,704</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Deferred:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">- Local</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">- Foreign</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Income tax expense</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,704</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Labuan and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>United States of America</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Agape ATP Corporation is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of September 30, 2019, the operations in the United States of America incurred $524,482 of cumulative net operating losses which can be carried forward to offset future taxable income. The net operating loss carry forwards begin to expire in 2038, if unutilized. The tax valuation allowance for September 30, 2019 and 2018 are $110,141 and $76,559 respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Labuan</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the current laws of the Labuan, Agape ATP Corporation is governed under the Labuan Business Activity Act, 1990. The tax charge for such company is based on 3% of net audited profit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Hong Kong</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Agape ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of 16.5% on its assessable income derived from Hong Kong. Business income derived outside the Special Administrative Region is not subject to Hong Kong Profits Tax.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of September 30, 2019 and June 30, 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of<br /> September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of<br /> June 30, 2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Deferred tax assets:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Net operating loss carry forwards</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 61%; padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">-United States of America</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">110,141</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">92,069</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">-Hong Kong</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less: valuation allowance</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(110,141</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(92,069</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Deferred tax asset</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>13. CONCENTRATIONS OF RISKS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(a) Major customers</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended September 30, 2019, the customers who accounted for 10% or more of the Company&#8217;s revenues and its account receivables balance at period-end are presented as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">For the three months ended<br /> September 30, 2019</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">As of<br /> September 30, 2019</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Revenue</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Percentage of revenue</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Accounts<br /> receivable</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%"><font style="font: 10pt Times New Roman, Times, Serif">Customer A</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">236,736</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">628,583</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total:</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">236,736</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">628,583</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended September 30, 2018, the customers who accounted for 10% or more of the Company&#8217;s revenues and its account receivables balance at period-end are presented as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">For the three months ended<br /> September 30, 2018</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">As of<br /> September 30, 2018</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Revenue</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Percentage of revenue</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Accounts<br /> receivable</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%"><font style="font: 10pt Times New Roman, Times, Serif">Customer A</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">415,367</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13,264</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total:</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">415,367</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13,264</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(b) Major vendors</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended September 30, 2019, the vendors who accounted for 10% or more of the Company&#8217;s purchases and its account payables balance at period-end are presented as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">For the three months ended<br /> September 30, 2019</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">As of<br /> September 30, 2019</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Purchases</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Percentage of purchases</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Accounts payable</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%"><font style="font: 10pt Times New Roman, Times, Serif">Vendor A</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">210,383</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 13%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total:</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">210,383</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended September 30, 2018, the vendors who accounted for 10% or more of the Company&#8217;s purchases and its account payables balance at period-end are presented as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">For the three months ended<br /> September 30, 2018</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">As of<br /> September 30, 2018</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Purchases</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Percentage of purchases</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Accounts payable</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%"><font style="font: 10pt Times New Roman, Times, Serif">Vendor A</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">314,423</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 13%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">83</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">47,641</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Vendor B</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">64,000</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total:</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">378,423</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">47,641</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(c) Credit risk</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(d) Exchange rate risk</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of RM$ converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(a) Major customers</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended September 30, 2019, the customers who accounted for 10% or more of the Company&#8217;s revenues and its account receivables balance at period-end are presented as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">For the three months ended<br /> September 30, 2019</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">As of<br /> September 30, 2019</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Revenue</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Percentage of revenue</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Accounts<br /> receivable</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%"><font style="font: 10pt Times New Roman, Times, Serif">Customer A</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">236,736</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">628,583</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total:</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">236,736</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">628,583</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended September 30, 2018, the customers who accounted for 10% or more of the Company&#8217;s revenues and its account receivables balance at period-end are presented as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">For the three months ended<br /> September 30, 2018</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">As of<br /> September 30, 2018</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Revenue</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Percentage of revenue</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Accounts<br /> receivable</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%"><font style="font: 10pt Times New Roman, Times, Serif">Customer A</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">415,367</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13,264</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total:</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">415,367</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13,264</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(b) Major vendors</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended September 30, 2019, the vendors who accounted for 10% or more of the Company&#8217;s purchases and its account payables balance at period-end are presented as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">For the three months ended<br /> September 30, 2019</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">As of<br /> September 30, 2019</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Purchases</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Percentage of purchases</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Accounts payable</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%"><font style="font: 10pt Times New Roman, Times, Serif">Vendor A</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">210,383</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 13%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total:</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">210,383</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended September 30, 2018, the vendors who accounted for 10% or more of the Company&#8217;s purchases and its account payables balance at period-end are presented as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">For the three months ended<br /> September 30, 2018</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">As of<br /> September 30, 2018</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Purchases</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Percentage of purchases</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Accounts payable</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%"><font style="font: 10pt Times New Roman, Times, Serif">Vendor A</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">314,423</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 13%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">83</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 13%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">47,641</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Vendor B</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">64,000</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total:</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">378,423</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">47,641</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> -3308 -3308 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Investment in non-marketable securities</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Investments in non-marketable equity securities (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>4. INVESTMENT IN NON-MARKETABLE SECURITIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company invested in Unreserved Sdn Bhd with the investment amount of $863,592 (MYR3,500,000), approximated 20% of equity interest of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. On March 10, 2019 Unreserved Sdn Bhd issued additional common stock for working capital. As the Company did not subscribe for the additional common stock, the Company&#8217;s equity interest in investee company was diluted from 20.0% to 17.86%. Effective March 10, 2019, the Company discontinued equity accounting on the investee company. The Company also ceased control over the operations of the investee company on the same date. Accordingly, investment in investee company was reclassified to investment in non-marketable securities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Unreserved Sdn Bhd is incorporated in Malaysia with 2,500,000 ordinary shares authorized, issued and outstanding. Mr Lim Hun Soon @ David Lim and Ms Aniza Helina Akmi Karim are the directors of Unreserved Sdn Bhd. Mr How Kok Choong was a director of the company from April 30,2018 to March 27, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 3, 2019, the Company purchased 5% of 300,000,000 or 15,000,000 common stocks in Phoenix Plus Corp. for $1,500 at purchase price of $0.0001 per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">Unreserved Sdn Bhd</font></td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of<br /> September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of<br /> June 30, 2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 63%"><font style="font: 10pt Times New Roman, Times, Serif">Cost of investment</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">832,335</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">832,335</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif"><i>Less: share of result of investee company</i></font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(124,225</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(124,225</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif"><i>Add: gain on deemed disposal of shares in investee company</i></font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">16,509</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">16,509</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Investment in investee company</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">724,619</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">724,619</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Reclassify to investment in non-marketable securities</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(724,619</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(724,619</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Investment in investee company</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Investment in non-marketable securities</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">724,619</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">724,619</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif"><u>Phoenix Plus Corporation</u></font></td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Cost of investment</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,500</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,500</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total investment in non-marketable securities</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">726,119</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">726,119</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">Unreserved Sdn Bhd</font></td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of<br /> September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of<br /> June 30, 2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 63%"><font style="font: 10pt Times New Roman, Times, Serif">Cost of investment</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">832,335</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">832,335</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif"><i>Less: share of result of investee company</i></font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(124,225</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(124,225</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif"><i>Add: gain on deemed disposal of shares in investee company</i></font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">16,509</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">16,509</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Investment in investee company</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">724,619</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">724,619</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Reclassify to investment in non-marketable securities</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(724,619</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(724,619</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Investment in investee company</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Investment in non-marketable securities</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">724,619</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">724,619</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif"><u>Phoenix Plus Corporation</u></font></td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Cost of investment</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,500</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,500</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total investment in non-marketable securities</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">726,119</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">726,119</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> Yes Yes false 726119 724619 726119 724619 860285 860285 2857587 2753080 498335 362049 2210 2202 3869742 3745914 4730027 4606199 110591 123292 149674 127218 149674 127218 37628 37628 5293082 5293082 -79 -3387 -750278 -848342 4730027 4606199 116973 13264 628583 745 -136286 107250 -8 -35145 47641 12701 -12000 -101199 307005 -3308 -104507 307005 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>6. TRADE RECEIVABLES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2019</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 63%"><font style="font: 10pt Times New Roman, Times, Serif">Trade receivables</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">628,583</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">511,610</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total trade receivables</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">628,583</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">511,610</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Investment in investee company</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates investment in investee company as it holds an equity interest based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>9. STOCKHOLDERS&#8217; EQUITY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2019, and June 30, 2019, there were 376,275,500 of common stocks issued and outstanding. There was no common stock issued and outstanding from the IPO as of September 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There were no stock options, warrants or other potentially dilutive securities outstanding as of September 30, 2019.</p> <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2019</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 63%"><font style="font: 10pt Times New Roman, Times, Serif">Trade receivables</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">628,583</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">511,610</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total trade receivables</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">628,583</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">511,610</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> 0.05 1.00 1.00 1.00 0.20 0.200 0.1786 Agape ATP Corporation Agape ATP International Holding Limited Labuan, March 6, 2017 Hong Kong, June 1, 2017 100 shares of ordinary share of US$1 each 1,000,000 shares of ordinary share of HK$1 each Investment holding Health and wellness products and health solution advisory services Greater than 50% 4.19 4.14 4.18 4.09 7.84 7.83 7.84 7.85 1.48 1.47 1 1 1 1 1 1 500000 1000 501000 1500 832335 1500 501000 863592 3500000 832335 1500 300000000 15000000 -124225 -124225 16509 16509 -724619 -724619 353214 265691 2504373 2487389 0.0325 0.0295 21081 12420 477254 349629 Mr How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape S.E.A. Sdn Bhd Mr How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape ATP (Asia) Limited. Mr How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of Agape Superior Living Pty Ltd 20000 2500 6417 78231 77962 12360 36413 524482 2038 0.03 0.165 -86056 -21497 -22072 10064 -81004 -29661 3704 92069 110141 92069 110141 110141 76559 0.10 0.10 0.10 0.10 1.00 1.00 1.00 1.00 1.00 0.83 0.17 1.00 1.00 511610 511610 628583 13264 628583 628583 13264 236736 415367 236736 415367 236736 415367 2204 35024 <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="background-color: white"> <td style="vertical-align: bottom; width: 30%"><font style="font: 10pt Times New Roman, Times, Serif"><u>Related parties</u></font></td> <td style="vertical-align: top; width: 1%">&#160;</td> <td style="vertical-align: top; width: 69%"><font style="font: 10pt Times New Roman, Times, Serif"><u>Relationships</u></font></td></tr> <tr style="vertical-align: top; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Agape S.E.A. Sdn Bhd</font></td> <td>&#160;</td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Mr How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape S.E.A. Sdn Bhd</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Agape Superior Living Pty Ltd</font></td> <td>&#160;</td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Mr How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of Agape Superior Living Pty Ltd</font></td></tr> <tr style="vertical-align: top; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Agape ATP (Asia) Limited</font></td> <td>&#160;</td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Mr How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape ATP (Asia) Limited.</font></td></tr> </table> <p style="margin: 0pt"></p> 471931 -12 366834 366834 EX-101.SCH 5 aatp-20190930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Losses (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization and Business Background link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Investment in Marketable Securities link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Investment In Non-Marketable Securities link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Cash and Cash Equivalents link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Trade Receivables link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Prepayments and Deposits link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Other Payables and Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Amount Due to a Director link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Concentrations of Risks link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Organization and Business Background (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Investment in Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Investment In Non-Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Trade Receivables (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Prepayments and Deposits (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Related Party Transactions (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Other Payables and Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Concentrations of Risks (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Organization and Business Background (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Organization and Business Background - Schedule of Subsidiaries and Associates (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Investment in Marketable Securities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Investment in Marketable Securities - Schedule of Investment in Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Investment in Non-Marketable Securities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Investment in Non-Marketable Securities - Schedule of Investment in Non Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Cash and Cash Equivalents (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Trade Receivables - Schedule of Trade Receivables (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Prepayments and Deposits - Schedule of Prepaid Expenses and Deposits (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Related Party Transactions - Schedule of Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Related Party Transactions - Schedule of Related Parties Relationships (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Stockholders' Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Other Payables and Accrued Liabilities - Schedule of Other Payables and Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Income Taxes - Schedule of Components of Income/(Loss) Before Income Tax (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Income Taxes - Schedule of Provision for Income Tax (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Amount Due to a Director (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Concentrations of Risks (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Concentrations of Risks - Schedule of Concentrations of Risks (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 aatp-20190930_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 aatp-20190930_def.xml XBRL DEFINITION FILE EX-101.LAB 8 aatp-20190930_lab.xml XBRL LABEL FILE Geographical [Axis] United States of America [Member] Legal Entity [Axis] Greenpro Capital Corp. [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-In Capital [Member] Accumulated Losses [Member] Hong Kong [Member] Accumulated Other Comprehensive Income/(Loss) [Member] Phoenix Plus Corporation [Member] Title of Individual [Axis] Directors of Unreserved Investments [Member] Receivable Type [Axis] Trade Receivable [Member] Additional Paid-in Capital [Member] Consolidated Entities [Axis] Agape ATP International Holding Limited [Member] Subsidiary Company [Member] Subsidiary Company One [Member] Variable Rate [Axis] Period-end MYR [Member] Period-average MYR [Member] Period-end HKD [Member] Period-average HKD [Member] Period-end AUD [Member] Period-average AUD [Member] Award Type [Axis] MYR Currency [Member] HKD Currency [Member] AUD Currency [Member] Director [Member] Statistical Measurement [Axis] Maximum [Member] Minimum [Member] Related Party [Axis] Agape S.E.A. Sdn Bhd [Member] Agape ATP (Asia) Limited [Member] Agape Superior Living Pty Ltd [Member] Sale of Stock [Axis] Initial Public Offering [Member] Stock Options [Member] Warrants [Member] Other [Member] Labuan [Member] Customer [Axis] Customer [Member] Vendor [Member] Concentration Risk Benchmark [Axis] Sales Revenue, Net [Member] Concentration Risk Type [Axis] Customer A [Member] Accounts Receivable [Member] Cost of Sales [Member] Vendor A [Member] Vendor B [Member] Extinguishment of Debt [Axis] Accounts Payable [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Flag Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS NON-CURRENT ASSETS Investment in marketable securities Investment in non-marketable securities Total Non-Current Assets CURRENT ASSETS Cash and cash equivalents Trade receivables Prepayments and deposits Amount due from a related party Total Current Assets TOTAL ASSETS STOCKHOLDERS' EQUITY AND LIABILITIES STOCKHOLDERS' EQUITY Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding Common Stock, par value $0.0001; 1,000,000,000 shares authorized, 376,275,500 and 376,275,500 issued and outstanding as of September 30, 2019 and June 30, 2019 Additional paid in capital Accumulated other comprehensive income/(losses) Accumulated losses TOTAL STOCKHOLDERS' EQUITY CURRENT LIABILITIES Trade payables Other payables and accrued liabilities Amount due to a director Total Current Liabilities TOTAL LIABILITIES TOTAL STOCKHOLDERS' EQUITY AND LIABILITIES Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] REVENUE COST OF REVENUE GROSS PROFIT OTHER INCOME SELLING, GENERAL AND ADMINISTRATIVE AND OPERATING EXPENSES LOSS BEFORE RESULTS OF INVESTEE COMPANY SHARE OF RESULTS OF INVESTEE COMPANY LOSS BEFORE INCOME TAX TAXATION NET LOSS Other comprehensive income/(loss): - Foreign currency translation adjustment TOTAL COMPREHENSIVE LOSS Net loss per share- Basic and diluted Weighted average number of common shares outstanding - Basic and diluted Statement [Table] Statement [Line Items] Balance Balance, shares Foreign currency translation adjustment Net loss Balance Balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash used in operating activities: Share of result of investee company Taxation Changes in operating assets and liabilities: Accounts receivables Prepayments and deposits Amount due from a related party Accounts payables Other payables and accrued liabilities Deposit received Amount due to director Net cash (used in) / provided by operating activities Effect of exchange rate changes on cash and cash equivalents Net change in cash and cash equivalents Cash and cash equivalents, beginning of period CASH AND CASH EQUIVALENTS, END OF PERIOD SUPPLEMENTAL CASH FLOWS INFORMATION Income taxes paid Interest paid Accounting Policies [Abstract] Organization and Business Background Summary of Significant Accounting Policies Investments, Debt and Equity Securities [Abstract] Investment in Marketable Securities Investment In Non-marketable Securities Investment In Non-Marketable Securities Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents Receivables [Abstract] Trade Receivables Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Prepayments and Deposits Related Party Transactions [Abstract] Related Party Transactions Equity [Abstract] Stockholders Equity Other Liabilities Disclosure [Abstract] Other Payables and Accrued Liabilities Income Tax Disclosure [Abstract] Income Taxes Amount Due to a Director Risks and Uncertainties [Abstract] Concentrations of Risks Subsequent Events [Abstract] Subsequent Events Basis of Presentation Basis of Consolidation Use of Estimates Investment in Investee Company Investment in Marketable Securities Investment in Non-marketable Securities Cash and Cash Equivalents Accounts Receivable Revenue Recognition Cost of Revenue Selling, General, Administrative and Operating Expenses Income Taxes Net Loss Per Share Foreign Currencies Translation Related Parties Fair Value of Financial Instruments Recent Accounting Pronouncements Schedule of Subsidiaries and Associates Schedule of Translation Exchange Rates Schedule of Investment in Marketable Securities Schedule of Investment in Non Marketable Securities Schedule of Trade Receivables Schedule of Prepaid Expenses and Deposits Schedule of Related Party Transactions Schedule of Related Parties Relationships Schedule of Other Payables and Accrued Liabilities Schedule of Components of Income/(Loss) Before Income Tax Schedule of Provision for Income Tax Schedule of Deferred Tax Assets Schedule of Concentrations of Risks Ownership percentage Subsidiary company name Place and date of incorporation Particulars of issued capital Principal activities Proportional of ownership interest and voting power held Income tax examination, likelihood of unfavorable settlement Foreign Currency Exchange Rate, Translation Exchange rate Investment amount Purchased price per shares Cost of investment Less: Impairment in cost of investment Investment in marketable securities Equity interest percentage Ordinary shares authorized Ordinary shares issued Ordinary shares outstanding Shares purchased during period Share purchased price per share Less: share of result of investee company Add: gain on deemed disposal of shares in investee company Investment in investee company Reclassify to investment in non-marketable securities Investment in investee company Cash on hand Time deposits Percentage of Interest rate for time deposits Total trade receivables Prepaid expenses Deposits to supplier Total prepaid expenses and deposits Revenue Expenses paid on behalf Sundry Purchases Accounts Receivable, Trade Accounts Payable, Non-trade Related parties relationship, description Common stock, issued Common stock, outstanding Potentially dilutive securities outstanding Accrued audit fees Accrued professional fees Deposit received from customer Others Total payables and accrued liabilities Cumulative net operating loss Operating loss carryforwards expire year Valuation allowance Tax percentage Statutory income tax rate Local Foreign Loss before income tax Current, Local Current, Foreign Deferred, Local Deferred, Foreign Income tax expense Net operating loss carry forwards Less: valuation allowance Deferred tax asset Concentrations of risk percentage Purchase Accounts receivable Accounts payable Agape ATP International Holding Limited [Member] Amount Due to a Director [Text Block] Customer A [Member] Customer [Member] Customer [Member] Greenpro Capital Corp. [Member] Invetsee Company [Member] Investment in Marketable Securities [Text Block] Labuan [Member] Other [Member] Period-average HKD [Member] Period-average MYR [Member] Period-end HKD [Member] Period-end MYR [Member] Prepayments and Deposits [Text Block] Related Parties [Policy Text Block] Related party A [Member] Related party B [Member] Schedule of Other Payables and Accrued Liabilities [Table Text Block] Schedule of Prepaid Expenses and Deposits [Table Text Block] Subsidiary Company [Member] Subsidiary Company One [Member] Vendor A [Member] Vendor B [Member] Vendor [Member] Investment in non-marketable securities. Investment in non-marketable securities [Policy Text Block] Investment In Non- Marketable Securities [Text Block] Schedule of Investment in Non Marketable Securities [Table Text Block] Related Party C [Member] MYR Currency [Member] HKD Currency [Member] Adam Network Oneand Damon Member. Name of the company name. Place and date of incorporation. Particulars of issued capital. Principal activities. Period-end AUD [Member] Period-average AUD [Member] AUD Currency [Member] Impairment in cost of investment. Phoenix Plus Corporation [Member] Directors of Unreserved Investments [Member] Share of result of investee company. Reclassify to investment in non-marketable securities. Investment in investee company. Deposits to supplier. Agape S.E.A. Sdn Bhd [Member] Agape Superior Living Pty Ltd [Member] Greenpro Capital Corporation [Member] Agape Superior Living Sdn Bhd [Member] Agape ATP (Asia) Limited [Member] Related parties, relationships, description. Accrued audit fees current. Operating loss carryforwards expire year. Accounts payable, non-trade. Schedule of Related Parties Relationships [Table Text Block] Assets, Noncurrent Assets, Current Assets Stockholders' Equity Attributable to Parent Liabilities, Current Liabilities Liabilities and Equity Gross Profit Selling, General and Administrative Expense Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Shares, Outstanding Increase (Decrease) in Prepaid Expense Increase (Decrease) in Due from Related Parties, Current Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Marketable Securities, Policy [Policy Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Income Tax, Policy [Policy Text Block] ImpairmentInCostOfInvestment InvestmentInNonMarketableSecurities EX-101.PRE 9 aatp-20190930_pre.xml XBRL PRESENTATION FILE XML 10 R50.htm IDEA: XBRL DOCUMENT v3.19.3
Income Taxes - Schedule of Provision for Income Tax (Details) - USD ($)
3 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Income Tax Disclosure [Abstract]    
Current, Local
Current, Foreign 3,704
Deferred, Local
Deferred, Foreign
Income tax expense $ 3,704
XML 11 R54.htm IDEA: XBRL DOCUMENT v3.19.3
Concentrations of Risks - Schedule of Concentrations of Risks (Details) - USD ($)
3 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Jun. 30, 2019
Revenue $ 236,736 $ 415,367  
Purchase 210,383 378,423  
Accounts receivable 628,583 13,264 $ 511,610
Accounts payable 47,641 $ 35,145
Vendor A [Member] | Accounts Payable [Member]      
Accounts payable 47,641  
Vendor B [Member] | Accounts Payable [Member]      
Accounts payable    
Sales Revenue, Net [Member]      
Concentrations of risk percentage 100.00% 100.00%  
Sales Revenue, Net [Member] | Customer A [Member]      
Revenue $ 236,736 $ 415,367  
Concentrations of risk percentage 100.00% 100.00%  
Accounts Receivable [Member] | Customer A [Member]      
Accounts receivable $ 628,583 $ 13,264  
Cost of Sales [Member]      
Concentrations of risk percentage 100.00% 100.00%  
Cost of Sales [Member] | Vendor A [Member]      
Purchase $ 210,383 $ 314,423  
Concentrations of risk percentage 100.00% 83.00%  
Cost of Sales [Member] | Vendor B [Member]      
Purchase   $ 64,000  
Concentrations of risk percentage   17.00%  
EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 14 R12.htm IDEA: XBRL DOCUMENT v3.19.3
Trade Receivables
3 Months Ended
Sep. 30, 2019
Receivables [Abstract]  
Trade Receivables

6. TRADE RECEIVABLES

 

    As of     As of  
    September 30, 2019     June 30, 2019  
Trade receivables   $ 628,583     $ 511,610  
Total trade receivables   $ 628,583     $ 511,610  

XML 15 R16.htm IDEA: XBRL DOCUMENT v3.19.3
Other Payables and Accrued Liabilities
3 Months Ended
Sep. 30, 2019
Other Liabilities Disclosure [Abstract]  
Other Payables and Accrued Liabilities

10. OTHER PAYABLES AND ACCRUED LIABILITIES

 

    As of     As of  
    September 30, 2019     June 30, 2019  
Accrued audit fees     2,500       20,000  
Accrued professional fees     6,417       -  
Deposit received from customer     77,962       78,231  
Others     36,413       12,360  
Total payables and accrued liabilities   $ 123,292     $ 110,591  

XML 16 R39.htm IDEA: XBRL DOCUMENT v3.19.3
Investment in Non-Marketable Securities (Details Narrative)
Sep. 30, 2019
USD ($)
shares
Sep. 30, 2019
MYR (RM)
shares
Jun. 30, 2019
USD ($)
shares
Apr. 03, 2019
USD ($)
$ / shares
shares
Ordinary shares authorized 1,000,000,000 1,000,000,000 1,000,000,000  
Ordinary shares issued 376,275,500 376,275,500 376,275,500  
Ordinary shares outstanding 376,275,500 376,275,500 376,275,500  
Phoenix Plus Corporation [Member]        
Investment amount | $ $ 1,500   $ 1,500 $ 1,500
Equity interest percentage       5.00%
Shares purchased during period       300,000,000
Share purchased price per share | $ / shares       $ 0.0001
Phoenix Plus Corporation [Member] | Common Stock [Member]        
Shares purchased during period       15,000,000
Maximum [Member]        
Equity interest percentage 20.00% 20.00%    
Minimum [Member]        
Equity interest percentage 17.86% 17.86%    
Director [Member]        
Investment amount | $ $ 863,592      
Equity interest percentage 20.00% 20.00%    
Ordinary shares authorized 2,500,000 2,500,000    
Ordinary shares issued 2,500,000 2,500,000    
Ordinary shares outstanding 2,500,000 2,500,000    
Director [Member] | MYR Currency [Member]        
Investment amount | RM   RM 3,500,000    
XML 17 R35.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details)
Sep. 30, 2019
Sep. 30, 2018
Period-end MYR [Member]    
Foreign Currency Exchange Rate, Translation 4.19 4.14
Period-average MYR [Member]    
Foreign Currency Exchange Rate, Translation 4.18 4.09
Period-end HKD [Member]    
Foreign Currency Exchange Rate, Translation 7.84 7.83
Period-average HKD [Member]    
Foreign Currency Exchange Rate, Translation 7.84 7.85
Period-end AUD [Member]    
Foreign Currency Exchange Rate, Translation 1.48
Period-average AUD [Member]    
Foreign Currency Exchange Rate, Translation 1.47
XML 18 R31.htm IDEA: XBRL DOCUMENT v3.19.3
Concentrations of Risks (Tables)
3 Months Ended
Sep. 30, 2019
Risks and Uncertainties [Abstract]  
Schedule of Concentrations of Risks

(a) Major customers

 

For the three months ended September 30, 2019, the customers who accounted for 10% or more of the Company’s revenues and its account receivables balance at period-end are presented as follows:

 

    For the three months ended
September 30, 2019
    As of
September 30, 2019
 
    Revenue     Percentage of revenue     Accounts
receivable
 
                   
Customer A   $ 236,736       100 %   $ 628,583  
Total:   $ 236,736       100 %   $ 628,583  

 

For the three months ended September 30, 2018, the customers who accounted for 10% or more of the Company’s revenues and its account receivables balance at period-end are presented as follows:

 

    For the three months ended
September 30, 2018
    As of
September 30, 2018
 
    Revenue     Percentage of revenue     Accounts
receivable
 
                   
Customer A   $ 415,367       100 %   $ 13,264  
Total:   $ 415,367       100 %   $ 13,264  

 

(b) Major vendors

 

For the three months ended September 30, 2019, the vendors who accounted for 10% or more of the Company’s purchases and its account payables balance at period-end are presented as follows:

 

    For the three months ended
September 30, 2019
    As of
September 30, 2019
 
    Purchases     Percentage of purchases     Accounts payable  
                   
Vendor A   $ 210,383       100 %   $ -  
Total:   $ 210,383       100 %   $ -  

 

For the three months ended September 30, 2018, the vendors who accounted for 10% or more of the Company’s purchases and its account payables balance at period-end are presented as follows:

 

    For the three months ended
September 30, 2018
    As of
September 30, 2018
 
    Purchases     Percentage of purchases     Accounts payable  
                   
Vendor A   $ 314,423       83 %   $ 47,641  
Vendor B     64,000       17 %     -  
Total:   $ 378,423       100 %   $ 47,641  

XML 19 R20.htm IDEA: XBRL DOCUMENT v3.19.3
Subsequent Events
3 Months Ended
Sep. 30, 2019
Subsequent Events [Abstract]  
Subsequent Events

14. SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after September 30, 2019 up through the date the Company issued the audited consolidated financial statements. During this period, there was no subsequent event that required recognition or disclosure.

XML 20 R24.htm IDEA: XBRL DOCUMENT v3.19.3
Investment in Marketable Securities (Tables)
3 Months Ended
Sep. 30, 2019
Investments, Debt and Equity Securities [Abstract]  
Schedule of Investment in Marketable Securities

    As of
September 30, 2019
    As of
June 30, 2019
 
Cost of investment   $ 501,000     $ 501,000  
Less: Impairment in cost of investment     (366,834 )     (366,834 )
Investment in marketable securities   $ 134,166     $ 134,166  

XML 21 R28.htm IDEA: XBRL DOCUMENT v3.19.3
Related Party Transactions (Tables)
3 Months Ended
Sep. 30, 2019
Related Party Transactions [Abstract]  
Schedule of Related Party Transactions

    Three Months Ended September 30,  
    2019     2018     2019     2018  
    Revenue     Accounts Receivable, Trade  
Agape S.E.A. Sdn Bhd   $ 236,736     $ 415,367     $ 628,583     $ 745  
                                 

 

    Expenses paid on behalf     Accounts Payable, Non-trade  
Agape ATP (Asia) Limited   $     -     $     -     $ 2,204     $    -  
                                 

 

    Sundry Purchases     Accounts Payable, Non-trade  
Agape Superior Living Pty Ltd   $     -     $     -     $ 35,024     $    -  

Schedule of Related Parties Relationships

Related parties   Relationships
Agape S.E.A. Sdn Bhd   Mr How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape S.E.A. Sdn Bhd
     
Agape Superior Living Pty Ltd   Mr How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of Agape Superior Living Pty Ltd
     
Agape ATP (Asia) Limited   Mr How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape ATP (Asia) Limited.

XML 22 R49.htm IDEA: XBRL DOCUMENT v3.19.3
Income Taxes - Schedule of Components of Income/(Loss) Before Income Tax (Details) - USD ($)
3 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Local $ (86,056) $ (21,497)
Loss before income tax (98,064) (132,162)
Labuan [Member]    
Foreign (22,072) (81,004)
Hong Kong [Member]    
Foreign $ 10,064 $ (29,661)
XML 23 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Organization and Business Background
3 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Organization and Business Background

1. ORGANIZATION AND BUSINESS BACKGROUND

 

Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016.

 

Agape ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.

 

Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.

 

The Company and its subsidiaries are involved in the health and wellness industry. The principal activity of the Company and its subsidiaries is to supply high-quality health and wellness products, including supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in our body.

 

Details of the Company’s subsidiaries:

 

    Subsidiary
company name
  Place and date of
incorporation
  Particulars of
issued capital
  Principal
activities
  Proportional of
ownership interest
and voting power held
 
1.   Agape ATP Corporation   Labuan,
March 6, 2017
  100 shares of ordinary share of US$1 each   Investment holding     100 %
                         
2.   Agape ATP International Holding Limited   Hong Kong,
June 1, 2017
  1,000,000 shares of ordinary share of HK$1 each   Health and wellness products and health solution advisory services     100 %

 

Business Overview

 

Agape ATP Corporation is a company that develops and provides health solution advisory services to our clients. We primarily focus our efforts on attracting customers in Malaysia. Our advisory services center on the “ATP Zeta Health Program”, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.

 

At its core, the ATP Zeta Super Health Program is focused upon biological energy, Adenosine Triphosphate (ATP), at the cellular level. The stimulation of ATP production at the cellular level can increase the metabolism and service to promote and maintain normal and healthy functioning of the body’s systems. As a strong advocator of “beauty from within”, our program shall emphasize nutrient absorption through the membrane ion channel to provide complete and balanced nutrients to improve cell health. Thus, ATP Zeta Super Health Program provides ionized and high zeta potential (high bioavailability) nutrients to enhance the absorption at the cellular level.

 

The ATP Zeta Super Health Program consists of ten products. None of these products are owned or produced by Agape ATP Corporation. In the event that any of these products are no longer produced, or are otherwise unavailable, we may have to devote significant effort to identifying and obtaining comparable replacement products. The ten products that comprise the ATP Zeta Super Health Program are ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, ATP5 BetaMaxx, AGN-Vege Fruit Fiber, AGP1-Iron, YFA-Young Formula, Mitogize and ORYC-Organic Youth Care Cleansing Bar.

 

At present, our products are mainly sold in Malaysia, and due to the contents and combination of the main ingredients in the products they are categorized as health food rather than medicines or drugs. As such, all products require authorization from the Food and Quality Division of Ministry of Health according to the Food Act of 1983 and Food Regulation 1985 in order to be sold in the country. All of the products in the ATP Zeta Super Health Program have obtained the appropriate authorizations.

 

As part of a continuous effort to increase market share of the health and wellness industry that is growing at an exponential rate, we will also evaluate adding additional products to the ATP Zeta Super Health Program; and considering the potential of the synergies between the health and beauty sectors, we will further involve ourselves in the topical approach of skin and hair regime.

XML 24 R3.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2019
Jun. 30, 2019
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 200,000,000 200,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 1,000,000,000 1,000,000,000
Common stock, shares issued 376,275,500 376,275,500
Common stock, shares outstanding 376,275,500 376,275,500
XML 25 R45.htm IDEA: XBRL DOCUMENT v3.19.3
Related Party Transactions - Schedule of Related Parties Relationships (Details)
3 Months Ended
Sep. 30, 2019
Agape S.E.A. Sdn Bhd [Member]  
Related parties relationship, description Mr How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape S.E.A. Sdn Bhd
Agape Superior Living Pty Ltd [Member]  
Related parties relationship, description Mr How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of Agape Superior Living Pty Ltd
Agape ATP (Asia) Limited [Member]  
Related parties relationship, description Mr How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape ATP (Asia) Limited.
ZIP 26 0001493152-19-016747-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-19-016747-xbrl.zip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end XML 27 R41.htm IDEA: XBRL DOCUMENT v3.19.3
Cash and Cash Equivalents (Details Narrative) - USD ($)
Sep. 30, 2019
Jun. 30, 2019
Cash and cash equivalents $ 2,753,080 $ 2,857,587
Cash on hand 265,691 353,214
Time deposits $ 2,487,389 $ 2,504,373
Minimum [Member]    
Percentage of Interest rate for time deposits 2.95%  
Maximum [Member]    
Percentage of Interest rate for time deposits 3.25%  
XML 28 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 29 R29.htm IDEA: XBRL DOCUMENT v3.19.3
Other Payables and Accrued Liabilities (Tables)
3 Months Ended
Sep. 30, 2019
Other Liabilities Disclosure [Abstract]  
Schedule of Other Payables and Accrued Liabilities

    As of     As of  
    September 30, 2019     June 30, 2019  
Accrued audit fees     2,500       20,000  
Accrued professional fees     6,417       -  
Deposit received from customer     77,962       78,231  
Others     36,413       12,360  
Total payables and accrued liabilities   $ 123,292     $ 110,591  

XML 30 R21.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Basis of Presentation

Basis of presentation

 

These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

Basis of Consolidation

Basis of consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.

Use of Estimates

Use of estimates

 

In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.

Investment in Investee Company

Investment in investee company

 

The Company evaluates investment in investee company as it holds an equity interest based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee.

Investment in Marketable Securities

Investment in marketable securities

 

Marketable securities included in marketable securities (current) and other investments (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities included in marketable securities (current) are stated at the lower of cost or market in the aggregate. and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary.

 

Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

Investment in Non-marketable Securities

Investment in non-marketable securities

 

Investments in non-marketable equity securities (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary.

 

Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

Cash and Cash Equivalents

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.

Accounts Receivable

Accounts receivable

 

Accounts receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on demand. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.

Revenue Recognition

Revenue recognition

 

In accordance with ASC Topic 605, “Revenue Recognition”, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured.

 

Revenue from supplies of healthy food products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded. Based on limited operating history, management estimates that there was no sale return for the period reported.

Cost of Revenue

Cost of revenue

 

Cost of revenue includes the purchase cost of manufactured goods for sale to customers It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

Selling, General, Administrative and Operating Expenses

Selling, general, administrative and operating expenses

 

Selling, general, administrative and operating expenses are primarily comprised of rental of office premises, licensing and professional fees.

Income Taxes

Income taxes

 

The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

Net Loss Per Share

Net loss per share

 

The Company calculates net loss per share in accordance with ASC Topic 260 “Earnings per share”. Basic loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

Foreign Currencies Translation

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates is the Malaysian Ringgit (“MYR”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to itss functional currency.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

 

Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:

 

    As of and for the three months
ended September 30,
 
    2019     2018  
             
Period-end MYR : US$1 exchange rate     4.19       4.14  
Period-average MYR : US$1 exchange rate     4.18       4.09  
Period-end HKD : US$1 exchange rate     7.84       7.83  
Period-average HKD : US$1 exchange rate     7.84       7.85  
Period-end AUD : US$1 exchange rate     1.48       -  
Period-average AUD : US$1 exchange rate     1.47       -  

Related Parties

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

Fair Value of Financial Instruments

Fair value of financial instruments:

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1: Observable inputs such as quoted prices in active markets;
   
  Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
   
  Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

Recent Accounting Pronouncements

Recent accounting pronouncements

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:

 

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605)”, and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. In August 2015, the FASB issued an Accounting Standards Update to defer by one year the effective dates of its new revenue recognition standard until annual reporting periods beginning after December 15, 2017 (2018 for calendar-year public entities) and interim periods therein. Management is currently assessing the impact of the adoption of ASU 2014-09 and has not determined the effect of the standard on our ongoing financial reporting.

 

In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. The Company is evaluating this ASU and has not determined the effect of this standard on its ongoing financial reporting.

 

In January 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business”, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This amendment was effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU No. 2017-01 did not have a material impact on the Company’s financial position, results of operations and liquidity.

 

In September 2017, the FASB has issued ASU No. 2017-13, Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.” The amendments in ASU No. 2017-13 amends the early adoption date option for certain companies related to the adoption of ASU No. 2014-09 and ASU No. 2016-02. Both of the below entities may still adopt using the public company adoption guidance in the related ASUs, as amended. The effective date is the same as the effective date and transition requirements for the amendments for ASU 2014-09 and ASU 2016-02.

 

In February 2018, the FASB has issued ASU No. 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220), which allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act. Consequently, the amendments eliminate the stranded tax effects resulting from the Tax Cuts and Jobs Act and will improve the usefulness of information in financial statement. The amendments in this ASU are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. The Company has analyzed the consequences of such adoption and has not determined the effect of this standard on its ongoing financial reporting.

 

In August 2018, the FASB has issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements of Fair Value Measurement. This amendment modifies the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, based on the concepts in the Concepts Statement, including the consideration of costs and benefits, with the primary purpose to improve the effectiveness of disclosures in the notes to financial statements by facilitating clear communication of the information required by US GAAP. The amendments in this update are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.

XML 31 R25.htm IDEA: XBRL DOCUMENT v3.19.3
Investment In Non-Marketable Securities (Tables)
3 Months Ended
Sep. 30, 2019
Investment In Non-marketable Securities  
Schedule of Investment in Non Marketable Securities

Unreserved Sdn Bhd   As of
September 30, 2019
    As of
June 30, 2019
 
Cost of investment   $ 832,335     $ 832,335  
Less: share of result of investee company     (124,225 )     (124,225 )
Add: gain on deemed disposal of shares in investee company     16,509       16,509  
Investment in investee company   $ 724,619     $ 724,619  
Reclassify to investment in non-marketable securities     (724,619 )     (724,619 )
Investment in investee company   $ -       -  
Investment in non-marketable securities   $ 724,619     $ 724,619  
                 
Phoenix Plus Corporation            
Cost of investment   $ 1,500     $ 1,500  
                 
Total investment in non-marketable securities   $ 726,119     $ 726,119  

XML 32 R44.htm IDEA: XBRL DOCUMENT v3.19.3
Related Party Transactions - Schedule of Related Party Transactions (Details) - USD ($)
3 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Revenue $ 236,736 $ 415,367
Accounts Receivable, Trade 116,973 13,264
Agape S.E.A. Sdn Bhd [Member]    
Revenue 236,736 415,367
Accounts Receivable, Trade 628,583 745
Agape ATP (Asia) Limited [Member]    
Expenses paid on behalf
Accounts Payable, Non-trade 2,204
Agape Superior Living Pty Ltd [Member]    
Sundry Purchases
Accounts Payable, Non-trade $ 35,024
XML 33 R40.htm IDEA: XBRL DOCUMENT v3.19.3
Investment in Non-Marketable Securities - Schedule of Investment in Non Marketable Securities (Details) - USD ($)
Sep. 30, 2019
Jun. 30, 2019
Apr. 03, 2019
Investment in non-marketable securities $ 726,119 $ 726,119  
Phoenix Plus Corporation [Member]      
Cost of investment 1,500 1,500 $ 1,500
Directors of Unreserved Investments [Member]      
Cost of investment 832,335 832,335  
Less: share of result of investee company (124,225) (124,225)  
Add: gain on deemed disposal of shares in investee company 16,509 16,509  
Investment in investee company 724,619 724,619  
Reclassify to investment in non-marketable securities (724,619) (724,619)  
Investment in investee company  
Investment in non-marketable securities $ 724,619 $ 724,619  
XML 34 R48.htm IDEA: XBRL DOCUMENT v3.19.3
Income Taxes (Details Narrative) - USD ($)
3 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Sep. 30, 2018
Valuation allowance $ 110,141 $ 92,069  
United States of America [Member]      
Cumulative net operating loss $ 524,482    
Operating loss carryforwards expire year 2038    
Valuation allowance $ 110,141   $ 76,559
Labuan [Member]      
Tax percentage 3.00%    
Hong Kong [Member]      
Statutory income tax rate 16.50%    
XML 35 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2019
Sep. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (98,064) $ (135,866)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share of result of investee company 52,109
Taxation 3,704
Changes in operating assets and liabilities:    
Accounts receivables (116,973) (13,264)
Prepayments and deposits 136,286 (107,250)
Amount due from a related party 8
Accounts payables (35,145) 47,641
Other payables and accrued liabilities 12,701 (12,000)
Deposit received 471,931
Amount due to director (12)
Net cash (used in) / provided by operating activities (101,199) 307,005
Effect of exchange rate changes on cash and cash equivalents (3,308)
Net change in cash and cash equivalents (104,507) 307,005
Cash and cash equivalents, beginning of period 2,857,587 3,531,255
CASH AND CASH EQUIVALENTS, END OF PERIOD 2,753,080 3,838,260
SUPPLEMENTAL CASH FLOWS INFORMATION    
Income taxes paid
Interest paid
XML 36 R2.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Balance Sheets - USD ($)
Sep. 30, 2019
Jun. 30, 2019
NON-CURRENT ASSETS    
Investment in marketable securities $ 134,166 $ 134,166
Investment in non-marketable securities 726,119 726,119
Total Non-Current Assets 860,285 860,285
CURRENT ASSETS    
Cash and cash equivalents 2,753,080 2,857,587
Trade receivables 628,583 511,610
Prepayments and deposits 362,049 498,335
Amount due from a related party 2,202 2,210
Total Current Assets 3,745,914 3,869,742
TOTAL ASSETS 4,606,199 4,730,027
STOCKHOLDERS' EQUITY    
Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding
Common Stock, par value $0.0001; 1,000,000,000 shares authorized, 376,275,500 and 376,275,500 issued and outstanding as of September 30, 2019 and June 30, 2019 37,628 37,628
Additional paid in capital 5,293,082 5,293,082
Accumulated other comprehensive income/(losses) (3,387) (79)
Accumulated losses (848,342) (750,278)
TOTAL STOCKHOLDERS' EQUITY 4,478,981 4,580,353
CURRENT LIABILITIES    
Trade payables 35,145
Other payables and accrued liabilities 123,292 110,591
Amount due to a director 3,926 3,938
Total Current Liabilities 127,218 149,674
TOTAL LIABILITIES 127,218 149,674
TOTAL STOCKHOLDERS' EQUITY AND LIABILITIES $ 4,606,199 $ 4,730,027
XML 37 R51.htm IDEA: XBRL DOCUMENT v3.19.3
Income Taxes - Schedule of Deferred Tax Assets (Details) - USD ($)
Sep. 30, 2019
Jun. 30, 2019
Sep. 30, 2018
Less: valuation allowance $ (110,141) $ (92,069)  
Deferred tax asset  
United States of America [Member]      
Net operating loss carry forwards 110,141 92,069  
Less: valuation allowance (110,141)   $ (76,559)
Hong Kong [Member]      
Net operating loss carry forwards  
XML 38 R13.htm IDEA: XBRL DOCUMENT v3.19.3
Prepayments and Deposits
3 Months Ended
Sep. 30, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Prepayments and Deposits

7. PREPAYMENTS AND DEPOSITS

 

    As of     As of  
    September 30, 2019     June 30, 2019  
Prepaid expenses   $ 12,420     $ 21,081  
Deposits to supplier     349,629       477,254  
Total prepaid expenses and deposits   $ 362,049     $ 498,335  

XML 39 R17.htm IDEA: XBRL DOCUMENT v3.19.3
Income Taxes
3 Months Ended
Sep. 30, 2019
Income Tax Disclosure [Abstract]  
Income Taxes

11. INCOME TAXES

 

For the three months ended September 30, 2019 and 2018, the local (United States) and foreign components of loss before income taxes were comprised of the following:

 

    Three Months Ended September 30,  
    2019     2018  
Tax jurisdictions from:                
- Local   $ (86,056 )   $ (21,497 )
- Foreign, representing                
Labuan     (22,072 )     (81,004 )
Hong Kong     10,064       (29,661 )
Loss before income tax   $ (98,064 )   $ (132,162 )

 

The provision for income taxes consisted of the following:

 

    Three Months Ended September 30,  
    2019     2018  
Current:                
- Local   $      -     $    -  
- Foreign     -       3,704  
                 
Deferred:                
- Local     -       -  
- Foreign     -       -  
                 
Income tax expense   $ -     $ 3,704  

 

The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Labuan and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:

 

United States of America

 

Agape ATP Corporation is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of September 30, 2019, the operations in the United States of America incurred $524,482 of cumulative net operating losses which can be carried forward to offset future taxable income. The net operating loss carry forwards begin to expire in 2038, if unutilized. The tax valuation allowance for September 30, 2019 and 2018 are $110,141 and $76,559 respectively.

 

Labuan

 

Under the current laws of the Labuan, Agape ATP Corporation is governed under the Labuan Business Activity Act, 1990. The tax charge for such company is based on 3% of net audited profit.

 

Hong Kong

 

Agape ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of 16.5% on its assessable income derived from Hong Kong. Business income derived outside the Special Administrative Region is not subject to Hong Kong Profits Tax.

 

The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of September 30, 2019 and June 30, 2019:

 

    As of
September 30, 2019
    As of
June 30, 2019
 
             
Deferred tax assets:                
Net operating loss carry forwards                
-United States of America     110,141       92,069  
-Hong Kong     -       -  
Less: valuation allowance     (110,141 )     (92,069 )
Deferred tax asset     -       -  

XML 40 R34.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Details Narrative)
3 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Income tax examination, likelihood of unfavorable settlement Greater than 50%
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.19.3
Income Taxes (Tables)
3 Months Ended
Sep. 30, 2019
Income Tax Disclosure [Abstract]  
Schedule of Components of Income/(Loss) Before Income Tax

For the three months ended September 30, 2019 and 2018, the local (United States) and foreign components of loss before income taxes were comprised of the following:

 

    Three Months Ended September 30,  
    2019     2018  
Tax jurisdictions from:                
- Local   $ (86,056 )   $ (21,497 )
- Foreign, representing                
Labuan     (22,072 )     (81,004 )
Hong Kong     10,064       (29,661 )
Loss before income tax   $ (98,064 )   $ (132,162 )

Schedule of Provision for Income Tax

The provision for income taxes consisted of the following:

 

    Three Months Ended September 30,  
    2019     2018  
Current:                
- Local   $      -     $    -  
- Foreign     -       3,704  
                 
Deferred:                
- Local     -       -  
- Foreign     -       -  
                 
Income tax expense   $ -     $ 3,704  

Schedule of Deferred Tax Assets

The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of September 30, 2019 and June 30, 2019:

 

    As of
September 30, 2019
    As of
June 30, 2019
 
             
Deferred tax assets:                
Net operating loss carry forwards                
-United States of America     110,141       92,069  
-Hong Kong     -       -  
Less: valuation allowance     (110,141 )     (92,069 )
Deferred tax asset     -       -  

XML 42 R38.htm IDEA: XBRL DOCUMENT v3.19.3
Investment in Marketable Securities - Schedule of Investment in Marketable Securities (Details) - USD ($)
Sep. 30, 2019
Jun. 30, 2019
Oct. 16, 2018
May 17, 2018
Investment in marketable securities $ 134,166 $ 134,166    
Greenpro Capital Corp. [Member]        
Cost of investment 501,000 501,000 $ 1,000 $ 500,000
Less: Impairment in cost of investment (366,834) (366,834)    
Investment in marketable securities $ 134,166 $ 134,166    
XML 43 R23.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Schedule of Translation Exchange Rates

Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:

 

    As of and for the three months
ended September 30,
 
    2019     2018  
             
Period-end MYR : US$1 exchange rate     4.19       4.14  
Period-average MYR : US$1 exchange rate     4.18       4.09  
Period-end HKD : US$1 exchange rate     7.84       7.83  
Period-average HKD : US$1 exchange rate     7.84       7.85  
Period-end AUD : US$1 exchange rate     1.48       -  
Period-average AUD : US$1 exchange rate     1.47       -  

XML 44 R27.htm IDEA: XBRL DOCUMENT v3.19.3
Prepayments and Deposits (Tables)
3 Months Ended
Sep. 30, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of Prepaid Expenses and Deposits

    As of     As of  
    September 30, 2019     June 30, 2019  
Prepaid expenses   $ 12,420     $ 21,081  
Deposits to supplier     349,629       477,254  
Total prepaid expenses and deposits   $ 362,049     $ 498,335  

XML 45 R46.htm IDEA: XBRL DOCUMENT v3.19.3
Stockholders' Equity (Details Narrative) - shares
3 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Common stock, issued 376,275,500 376,275,500
Common stock, outstanding 376,275,500 376,275,500
Warrants [Member]    
Potentially dilutive securities outstanding  
Stock Options [Member]    
Potentially dilutive securities outstanding  
Other [Member]    
Potentially dilutive securities outstanding  
Initial Public Offering [Member]    
Common stock, issued  
Common stock, outstanding  
XML 46 R8.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies
3 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The accompanying consolidated financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying consolidated financial statements and notes.

 

Basis of presentation

 

These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

 

Basis of consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.

 

Use of estimates

 

In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

Investment in investee company

 

The Company evaluates investment in investee company as it holds an equity interest based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee.

 

Investment in marketable securities

 

Marketable securities included in marketable securities (current) and other investments (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities included in marketable securities (current) are stated at the lower of cost or market in the aggregate. and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary.

 

Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

 

Investment in non-marketable securities

 

Investments in non-marketable equity securities (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary.

 

Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.

 

Accounts receivable

 

Accounts receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on demand. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.

 

Revenue recognition

 

In accordance with ASC Topic 605, “Revenue Recognition”, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured.

 

Revenue from supplies of healthy food products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded. Based on limited operating history, management estimates that there was no sale return for the period reported.

 

Cost of revenue

 

Cost of revenue includes the purchase cost of manufactured goods for sale to customers It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

 

Selling, general, administrative and operating expenses

 

Selling, general, administrative and operating expenses are primarily comprised of rental of office premises, licensing and professional fees.

 

Income taxes

 

The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 

Net loss per share

 

The Company calculates net loss per share in accordance with ASC Topic 260 “Earnings per share”. Basic loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income.

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates is the Malaysian Ringgit (“MYR”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to itss functional currency.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

 

Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:

 

    As of and for the three months
ended September 30,
 
    2019     2018  
             
Period-end MYR : US$1 exchange rate     4.19       4.14  
Period-average MYR : US$1 exchange rate     4.18       4.09  
Period-end HKD : US$1 exchange rate     7.84       7.83  
Period-average HKD : US$1 exchange rate     7.84       7.85  
Period-end AUD : US$1 exchange rate     1.48       -  
Period-average AUD : US$1 exchange rate     1.47       -  

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Fair value of financial instruments:

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1: Observable inputs such as quoted prices in active markets;
   
  Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
   
  Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

 

Recent accounting pronouncements

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:

 

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605)”, and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. In August 2015, the FASB issued an Accounting Standards Update to defer by one year the effective dates of its new revenue recognition standard until annual reporting periods beginning after December 15, 2017 (2018 for calendar-year public entities) and interim periods therein. Management is currently assessing the impact of the adoption of ASU 2014-09 and has not determined the effect of the standard on our ongoing financial reporting.

 

In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. The Company is evaluating this ASU and has not determined the effect of this standard on its ongoing financial reporting.

 

In January 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business”, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This amendment was effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU No. 2017-01 did not have a material impact on the Company’s financial position, results of operations and liquidity.

 

In September 2017, the FASB has issued ASU No. 2017-13, Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.” The amendments in ASU No. 2017-13 amends the early adoption date option for certain companies related to the adoption of ASU No. 2014-09 and ASU No. 2016-02. Both of the below entities may still adopt using the public company adoption guidance in the related ASUs, as amended. The effective date is the same as the effective date and transition requirements for the amendments for ASU 2014-09 and ASU 2016-02.

 

In February 2018, the FASB has issued ASU No. 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220), which allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act. Consequently, the amendments eliminate the stranded tax effects resulting from the Tax Cuts and Jobs Act and will improve the usefulness of information in financial statement. The amendments in this ASU are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. The Company has analyzed the consequences of such adoption and has not determined the effect of this standard on its ongoing financial reporting.

 

In August 2018, the FASB has issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements of Fair Value Measurement. This amendment modifies the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement, based on the concepts in the Concepts Statement, including the consideration of costs and benefits, with the primary purpose to improve the effectiveness of disclosures in the notes to financial statements by facilitating clear communication of the information required by US GAAP. The amendments in this update are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.

XML 47 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 48 R42.htm IDEA: XBRL DOCUMENT v3.19.3
Trade Receivables - Schedule of Trade Receivables (Details) - USD ($)
Sep. 30, 2019
Jun. 30, 2019
Sep. 30, 2018
Total trade receivables $ 628,583 $ 511,610 $ 13,264
Trade Receivable [Member]      
Total trade receivables $ 628,583 $ 511,610  
XML 49 R4.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Operations and Comprehensive Losses (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]    
REVENUE $ 236,736 $ 415,367
COST OF REVENUE (210,383) (378,423)
GROSS PROFIT 26,353 36,944
OTHER INCOME 19,865 1,621
SELLING, GENERAL AND ADMINISTRATIVE AND OPERATING EXPENSES (144,282) (118,618)
LOSS BEFORE RESULTS OF INVESTEE COMPANY (98,064) (80,053)
SHARE OF RESULTS OF INVESTEE COMPANY (52,109)
LOSS BEFORE INCOME TAX (98,064) (132,162)
TAXATION (3,704)
NET LOSS (98,064) (135,866)
Other comprehensive income/(loss):    
- Foreign currency translation adjustment (3,308)
TOTAL COMPREHENSIVE LOSS $ (101,372) $ (135,866)
Net loss per share- Basic and diluted $ (0.00) $ (0.00)
Weighted average number of common shares outstanding - Basic and diluted 376,275,500 376,275,500
XML 50 R53.htm IDEA: XBRL DOCUMENT v3.19.3
Concentrations of Risks (Details Narrative)
3 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Customer [Member]    
Concentrations of risk percentage 10.00% 10.00%
Vendor [Member]    
Concentrations of risk percentage 10.00% 10.00%
XML 51 R36.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) (Parenthetical) - USD ($)
3 Months Ended
Sep. 30, 2019
Sep. 30, 2018
MYR Currency [Member]    
Exchange rate $ 1 $ 1
HKD Currency [Member]    
Exchange rate 1 1
AUD Currency [Member]    
Exchange rate $ 1 $ 1
XML 52 R32.htm IDEA: XBRL DOCUMENT v3.19.3
Organization and Business Background (Details Narrative)
Sep. 30, 2019
Agape ATP International Holding Limited [Member]  
Ownership percentage 100.00%
XML 53 R11.htm IDEA: XBRL DOCUMENT v3.19.3
Cash and Cash Equivalents
3 Months Ended
Sep. 30, 2019
Cash and Cash Equivalents [Abstract]  
Cash and Cash Equivalents

5. CASH AND CASH EQUIVALENTS

 

As at September 30, 2019, the Company recorded $2,753,080 of cash and cash equivalents (June 30,2019: $2,857,587), which consists $265,691 of cash on hand (June 30,2019: $353,214) and $2,487,389 (June 30, 2019: $2,504,373) of time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments. The effective interest rate for the time deposits ranges between 2.95% to 3.25% per annum (September 30,2019: 2.95% to 3.25%).

XML 54 R15.htm IDEA: XBRL DOCUMENT v3.19.3
Stockholders' Equity
3 Months Ended
Sep. 30, 2019
Equity [Abstract]  
Stockholders Equity

9. STOCKHOLDERS’ EQUITY

 

As of September 30, 2019, and June 30, 2019, there were 376,275,500 of common stocks issued and outstanding. There was no common stock issued and outstanding from the IPO as of September 30, 2019.

 

There were no stock options, warrants or other potentially dilutive securities outstanding as of September 30, 2019.

XML 55 R19.htm IDEA: XBRL DOCUMENT v3.19.3
Concentrations of Risks
3 Months Ended
Sep. 30, 2019
Risks and Uncertainties [Abstract]  
Concentrations of Risks

13. CONCENTRATIONS OF RISKS

 

(a) Major customers

 

For the three months ended September 30, 2019, the customers who accounted for 10% or more of the Company’s revenues and its account receivables balance at period-end are presented as follows:

 

    For the three months ended
September 30, 2019
    As of
September 30, 2019
 
    Revenue     Percentage of revenue     Accounts
receivable
 
                   
Customer A   $ 236,736       100 %   $ 628,583  
Total:   $ 236,736       100 %   $ 628,583  

 

For the three months ended September 30, 2018, the customers who accounted for 10% or more of the Company’s revenues and its account receivables balance at period-end are presented as follows:

 

    For the three months ended
September 30, 2018
    As of
September 30, 2018
 
    Revenue     Percentage of revenue     Accounts
receivable
 
                   
Customer A   $ 415,367       100 %   $ 13,264  
Total:   $ 415,367       100 %   $ 13,264  

 

(b) Major vendors

 

For the three months ended September 30, 2019, the vendors who accounted for 10% or more of the Company’s purchases and its account payables balance at period-end are presented as follows:

 

    For the three months ended
September 30, 2019
    As of
September 30, 2019
 
    Purchases     Percentage of purchases     Accounts payable  
                   
Vendor A   $ 210,383       100 %   $ -  
Total:   $ 210,383       100 %   $ -  

 

For the three months ended September 30, 2018, the vendors who accounted for 10% or more of the Company’s purchases and its account payables balance at period-end are presented as follows:

 

    For the three months ended
September 30, 2018
    As of
September 30, 2018
 
    Purchases     Percentage of purchases     Accounts payable  
                   
Vendor A   $ 314,423       83 %   $ 47,641  
Vendor B     64,000       17 %     -  
Total:   $ 378,423       100 %   $ 47,641  

 

(c) Credit risk

 

Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

 

(d) Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of RM$ converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

XML 56 R52.htm IDEA: XBRL DOCUMENT v3.19.3
Amount Due to a Director (Details Narrative) - USD ($)
Sep. 30, 2019
Jun. 30, 2019
Related Party Transactions [Abstract]    
Amount due to a director $ 3,926 $ 3,938
XML 57 R37.htm IDEA: XBRL DOCUMENT v3.19.3
Investment in Marketable Securities (Details Narrative) - Greenpro Capital Corp. [Member] - USD ($)
Sep. 30, 2019
Jun. 30, 2019
Oct. 16, 2018
May 17, 2018
Investment amount $ 501,000 $ 501,000 $ 1,000 $ 500,000
Purchased price per shares     $ 0.03 $ 6
XML 58 R33.htm IDEA: XBRL DOCUMENT v3.19.3
Organization and Business Background - Schedule of Subsidiaries and Associates (Details)
3 Months Ended
Sep. 30, 2019
Subsidiary Company [Member]  
Subsidiary company name Agape ATP Corporation
Place and date of incorporation Labuan, March 6, 2017
Particulars of issued capital 100 shares of ordinary share of US$1 each
Principal activities Investment holding
Proportional of ownership interest and voting power held 100.00%
Subsidiary Company One [Member]  
Subsidiary company name Agape ATP International Holding Limited
Place and date of incorporation Hong Kong, June 1, 2017
Particulars of issued capital 1,000,000 shares of ordinary share of HK$1 each
Principal activities Health and wellness products and health solution advisory services
Proportional of ownership interest and voting power held 100.00%
XML 59 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 96 245 1 false 42 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://agapeatp.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://agapeatp.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://agapeatp.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Losses (Unaudited) Sheet http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveLosses Consolidated Statements of Operations and Comprehensive Losses (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Sheet http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://agapeatp.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Organization and Business Background Sheet http://agapeatp.com/role/OrganizationAndBusinessBackground Organization and Business Background Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Investment in Marketable Securities Sheet http://agapeatp.com/role/InvestmentInMarketableSecurities Investment in Marketable Securities Notes 9 false false R10.htm 00000010 - Disclosure - Investment In Non-Marketable Securities Sheet http://agapeatp.com/role/InvestmentInNon-marketableSecurities Investment In Non-Marketable Securities Notes 10 false false R11.htm 00000011 - Disclosure - Cash and Cash Equivalents Sheet http://agapeatp.com/role/CashAndCashEquivalents Cash and Cash Equivalents Notes 11 false false R12.htm 00000012 - Disclosure - Trade Receivables Sheet http://agapeatp.com/role/TradeReceivables Trade Receivables Notes 12 false false R13.htm 00000013 - Disclosure - Prepayments and Deposits Sheet http://agapeatp.com/role/PrepaymentsAndDeposits Prepayments and Deposits Notes 13 false false R14.htm 00000014 - Disclosure - Related Party Transactions Sheet http://agapeatp.com/role/RelatedPartyTransactions Related Party Transactions Notes 14 false false R15.htm 00000015 - Disclosure - Stockholders' Equity Sheet http://agapeatp.com/role/StockholdersEquity Stockholders' Equity Notes 15 false false R16.htm 00000016 - Disclosure - Other Payables and Accrued Liabilities Sheet http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities Other Payables and Accrued Liabilities Notes 16 false false R17.htm 00000017 - Disclosure - Income Taxes Sheet http://agapeatp.com/role/IncomeTaxes Income Taxes Notes 17 false false R18.htm 00000018 - Disclosure - Amount Due to a Director Sheet http://agapeatp.com/role/AmountDueToDirector Amount Due to a Director Notes 18 false false R19.htm 00000019 - Disclosure - Concentrations of Risks Sheet http://agapeatp.com/role/ConcentrationsOfRisks Concentrations of Risks Notes 19 false false R20.htm 00000020 - Disclosure - Subsequent Events Sheet http://agapeatp.com/role/SubsequentEvents Subsequent Events Notes 20 false false R21.htm 00000021 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies 21 false false R22.htm 00000022 - Disclosure - Organization and Business Background (Tables) Sheet http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables Organization and Business Background (Tables) Tables http://agapeatp.com/role/OrganizationAndBusinessBackground 22 false false R23.htm 00000023 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies 23 false false R24.htm 00000024 - Disclosure - Investment in Marketable Securities (Tables) Sheet http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables Investment in Marketable Securities (Tables) Tables http://agapeatp.com/role/InvestmentInMarketableSecurities 24 false false R25.htm 00000025 - Disclosure - Investment In Non-Marketable Securities (Tables) Sheet http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables Investment In Non-Marketable Securities (Tables) Tables http://agapeatp.com/role/InvestmentInNon-marketableSecurities 25 false false R26.htm 00000026 - Disclosure - Trade Receivables (Tables) Sheet http://agapeatp.com/role/TradeReceivablesTables Trade Receivables (Tables) Tables http://agapeatp.com/role/TradeReceivables 26 false false R27.htm 00000027 - Disclosure - Prepayments and Deposits (Tables) Sheet http://agapeatp.com/role/PrepaymentsAndDepositsTables Prepayments and Deposits (Tables) Tables http://agapeatp.com/role/PrepaymentsAndDeposits 27 false false R28.htm 00000028 - Disclosure - Related Party Transactions (Tables) Sheet http://agapeatp.com/role/RelatedPartyTransactionsTables Related Party Transactions (Tables) Tables http://agapeatp.com/role/RelatedPartyTransactions 28 false false R29.htm 00000029 - Disclosure - Other Payables and Accrued Liabilities (Tables) Sheet http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables Other Payables and Accrued Liabilities (Tables) Tables http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities 29 false false R30.htm 00000030 - Disclosure - Income Taxes (Tables) Sheet http://agapeatp.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://agapeatp.com/role/IncomeTaxes 30 false false R31.htm 00000031 - Disclosure - Concentrations of Risks (Tables) Sheet http://agapeatp.com/role/ConcentrationsOfRisksTables Concentrations of Risks (Tables) Tables http://agapeatp.com/role/ConcentrationsOfRisks 31 false false R32.htm 00000032 - Disclosure - Organization and Business Background (Details Narrative) Sheet http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative Organization and Business Background (Details Narrative) Details http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables 32 false false R33.htm 00000033 - Disclosure - Organization and Business Background - Schedule of Subsidiaries and Associates (Details) Sheet http://agapeatp.com/role/OrganizationAndBusinessBackground-ScheduleOfSubsidiariesAndAssociatesDetails Organization and Business Background - Schedule of Subsidiaries and Associates (Details) Details 33 false false R34.htm 00000034 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables 34 false false R35.htm 00000035 - Disclosure - Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfTranslationExchangeRatesDetails Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) Details 35 false false R36.htm 00000036 - Disclosure - Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) (Parenthetical) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfTranslationExchangeRatesDetailsParenthetical Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) (Parenthetical) Details 36 false false R37.htm 00000037 - Disclosure - Investment in Marketable Securities (Details Narrative) Sheet http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative Investment in Marketable Securities (Details Narrative) Details http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables 37 false false R38.htm 00000038 - Disclosure - Investment in Marketable Securities - Schedule of Investment in Marketable Securities (Details) Sheet http://agapeatp.com/role/InvestmentInMarketableSecurities-ScheduleOfInvestmentInMarketableSecuritiesDetails Investment in Marketable Securities - Schedule of Investment in Marketable Securities (Details) Details 38 false false R39.htm 00000039 - Disclosure - Investment in Non-Marketable Securities (Details Narrative) Sheet http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative Investment in Non-Marketable Securities (Details Narrative) Details 39 false false R40.htm 00000040 - Disclosure - Investment in Non-Marketable Securities - Schedule of Investment in Non Marketable Securities (Details) Sheet http://agapeatp.com/role/InvestmentInNon-marketableSecurities-ScheduleOfInvestmentInNonMarketableSecuritiesDetails Investment in Non-Marketable Securities - Schedule of Investment in Non Marketable Securities (Details) Details 40 false false R41.htm 00000041 - Disclosure - Cash and Cash Equivalents (Details Narrative) Sheet http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative Cash and Cash Equivalents (Details Narrative) Details http://agapeatp.com/role/CashAndCashEquivalents 41 false false R42.htm 00000042 - Disclosure - Trade Receivables - Schedule of Trade Receivables (Details) Sheet http://agapeatp.com/role/TradeReceivables-ScheduleOfTradeReceivablesDetails Trade Receivables - Schedule of Trade Receivables (Details) Details 42 false false R43.htm 00000043 - Disclosure - Prepayments and Deposits - Schedule of Prepaid Expenses and Deposits (Details) Sheet http://agapeatp.com/role/PrepaymentsAndDeposits-ScheduleOfPrepaidExpensesAndDepositsDetails Prepayments and Deposits - Schedule of Prepaid Expenses and Deposits (Details) Details 43 false false R44.htm 00000044 - Disclosure - Related Party Transactions - Schedule of Related Party Transactions (Details) Sheet http://agapeatp.com/role/RelatedPartyTransactions-ScheduleOfRelatedPartyTransactionsDetails Related Party Transactions - Schedule of Related Party Transactions (Details) Details 44 false false R45.htm 00000045 - Disclosure - Related Party Transactions - Schedule of Related Parties Relationships (Details) Sheet http://agapeatp.com/role/RelatedPartyTransactions-ScheduleOfRelatedPartiesRelationshipsDetails Related Party Transactions - Schedule of Related Parties Relationships (Details) Details 45 false false R46.htm 00000046 - Disclosure - Stockholders' Equity (Details Narrative) Sheet http://agapeatp.com/role/StockholdersEquityDetailsNarrative Stockholders' Equity (Details Narrative) Details http://agapeatp.com/role/StockholdersEquity 46 false false R47.htm 00000047 - Disclosure - Other Payables and Accrued Liabilities - Schedule of Other Payables and Accrued Liabilities (Details) Sheet http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities-ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails Other Payables and Accrued Liabilities - Schedule of Other Payables and Accrued Liabilities (Details) Details 47 false false R48.htm 00000048 - Disclosure - Income Taxes (Details Narrative) Sheet http://agapeatp.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://agapeatp.com/role/IncomeTaxesTables 48 false false R49.htm 00000049 - Disclosure - Income Taxes - Schedule of Components of Income/(Loss) Before Income Tax (Details) Sheet http://agapeatp.com/role/IncomeTaxes-ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails Income Taxes - Schedule of Components of Income/(Loss) Before Income Tax (Details) Details 49 false false R50.htm 00000050 - Disclosure - Income Taxes - Schedule of Provision for Income Tax (Details) Sheet http://agapeatp.com/role/IncomeTaxes-ScheduleOfProvisionForIncomeTaxDetails Income Taxes - Schedule of Provision for Income Tax (Details) Details 50 false false R51.htm 00000051 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details) Sheet http://agapeatp.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails Income Taxes - Schedule of Deferred Tax Assets (Details) Details 51 false false R52.htm 00000052 - Disclosure - Amount Due to a Director (Details Narrative) Sheet http://agapeatp.com/role/AmountDueToDirectorDetailsNarrative Amount Due to a Director (Details Narrative) Details http://agapeatp.com/role/AmountDueToDirector 52 false false R53.htm 00000053 - Disclosure - Concentrations of Risks (Details Narrative) Sheet http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative Concentrations of Risks (Details Narrative) Details http://agapeatp.com/role/ConcentrationsOfRisksTables 53 false false R54.htm 00000054 - Disclosure - Concentrations of Risks - Schedule of Concentrations of Risks (Details) Sheet http://agapeatp.com/role/ConcentrationsOfRisks-ScheduleOfConcentrationsOfRisksDetails Concentrations of Risks - Schedule of Concentrations of Risks (Details) Details 54 false false All Reports Book All Reports aatp-20190930.xml aatp-20190930.xsd aatp-20190930_cal.xml aatp-20190930_def.xml aatp-20190930_lab.xml aatp-20190930_pre.xml http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/country/2017-01-31 true true XML 60 R18.htm IDEA: XBRL DOCUMENT v3.19.3
Amount Due to a Director
3 Months Ended
Sep. 30, 2019
Related Party Transactions [Abstract]  
Amount Due to a Director

12. AMOUNT DUE TO A DIRECTOR

 

As of September 30, 2019 and June 30, 2019, a director of the Company advanced $3,926 and $3,938 respectively to the Company, which is unsecured, interest-free with no fixed repayment term, for working capital purpose. Imputed interest is considered insignificant.

XML 61 R10.htm IDEA: XBRL DOCUMENT v3.19.3
Investment In Non-Marketable Securities
3 Months Ended
Sep. 30, 2019
Investment In Non-marketable Securities  
Investment In Non-Marketable Securities

4. INVESTMENT IN NON-MARKETABLE SECURITIES

 

The Company invested in Unreserved Sdn Bhd with the investment amount of $863,592 (MYR3,500,000), approximated 20% of equity interest of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. On March 10, 2019 Unreserved Sdn Bhd issued additional common stock for working capital. As the Company did not subscribe for the additional common stock, the Company’s equity interest in investee company was diluted from 20.0% to 17.86%. Effective March 10, 2019, the Company discontinued equity accounting on the investee company. The Company also ceased control over the operations of the investee company on the same date. Accordingly, investment in investee company was reclassified to investment in non-marketable securities.

 

Unreserved Sdn Bhd is incorporated in Malaysia with 2,500,000 ordinary shares authorized, issued and outstanding. Mr Lim Hun Soon @ David Lim and Ms Aniza Helina Akmi Karim are the directors of Unreserved Sdn Bhd. Mr How Kok Choong was a director of the company from April 30,2018 to March 27, 2019.

 

On April 3, 2019, the Company purchased 5% of 300,000,000 or 15,000,000 common stocks in Phoenix Plus Corp. for $1,500 at purchase price of $0.0001 per share.

 

Unreserved Sdn Bhd   As of
September 30, 2019
    As of
June 30, 2019
 
Cost of investment   $ 832,335     $ 832,335  
Less: share of result of investee company     (124,225 )     (124,225 )
Add: gain on deemed disposal of shares in investee company     16,509       16,509  
Investment in investee company   $ 724,619     $ 724,619  
Reclassify to investment in non-marketable securities     (724,619 )     (724,619 )
Investment in investee company   $ -       -  
Investment in non-marketable securities   $ 724,619     $ 724,619  
                 
Phoenix Plus Corporation            
Cost of investment   $ 1,500     $ 1,500  
                 
Total investment in non-marketable securities   $ 726,119     $ 726,119  

XML 62 R14.htm IDEA: XBRL DOCUMENT v3.19.3
Related Party Transactions
3 Months Ended
Sep. 30, 2019
Related Party Transactions [Abstract]  
Related Party Transactions

8. RELATED PARTY TRANSACTIONS

 

    Three Months Ended September 30,  
    2019     2018     2019     2018  
    Revenue     Accounts Receivable, Trade  
Agape S.E.A. Sdn Bhd   $ 236,736     $ 415,367     $ 628,583     $ 745  
                                 

 

    Expenses paid on behalf     Accounts Payable, Non-trade  
Agape ATP (Asia) Limited   $     -     $     -     $ 2,204     $    -  
                                 

 

    Sundry Purchases     Accounts Payable, Non-trade  
Agape Superior Living Pty Ltd   $     -     $     -     $ 35,024     $    -  
                                 

 

Related parties   Relationships
Agape S.E.A. Sdn Bhd   Mr How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape S.E.A. Sdn Bhd
     
Agape Superior Living Pty Ltd   Mr How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of Agape Superior Living Pty Ltd
     
Agape ATP (Asia) Limited   Mr How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of Agape ATP (Asia) Limited.

XML 63 R22.htm IDEA: XBRL DOCUMENT v3.19.3
Organization and Business Background (Tables)
3 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Schedule of Subsidiaries and Associates

Details of the Company’s subsidiaries:

 

    Subsidiary
company name
  Place and date of
incorporation
  Particulars of
issued capital
  Principal
activities
  Proportional of
ownership interest
and voting power held
 
1.   Agape ATP Corporation   Labuan,
March 6, 2017
  100 shares of ordinary share of US$1 each   Investment holding     100 %
                         
2.   Agape ATP International Holding Limited   Hong Kong,
June 1, 2017
  1,000,000 shares of ordinary share of HK$1 each   Health and wellness products and health solution advisory services     100 %

XML 64 R26.htm IDEA: XBRL DOCUMENT v3.19.3
Trade Receivables (Tables)
3 Months Ended
Sep. 30, 2019
Receivables [Abstract]  
Schedule of Trade Receivables

    As of     As of  
    September 30, 2019     June 30, 2019  
Trade receivables   $ 628,583     $ 511,610  
Total trade receivables   $ 628,583     $ 511,610  

XML 65 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - 3 months ended Sep. 30, 2019 - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income/(Loss) [Member]
Accumulated Losses [Member]
Total
Balance at Jun. 30, 2019 $ 37,628 $ 5,293,082 $ (79) $ (750,278) $ 4,580,353
Balance, shares at Jun. 30, 2019 376,275,600        
Foreign currency translation adjustment (3,308) (3,308)
Net loss (98,064) (98,064)
Balance at Sep. 30, 2019 $ 37,628 $ 5,293,082 $ (3,387) $ (848,342) $ 4,478,981
Balance, shares at Sep. 30, 2019 376,275,600        
XML 66 R1.htm IDEA: XBRL DOCUMENT v3.19.3
Document and Entity Information - shares
3 Months Ended
Sep. 30, 2019
Nov. 08, 2019
Document And Entity Information    
Entity Registrant Name Agape ATP Corp  
Entity Central Index Key 0001713210  
Document Type 10-Q  
Document Period End Date Sep. 30, 2019  
Amendment Flag false  
Current Fiscal Year End Date --06-30  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business Flag false  
Entity Emerging Growth Company false  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   376,275,500
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2020  
XML 67 R47.htm IDEA: XBRL DOCUMENT v3.19.3
Other Payables and Accrued Liabilities - Schedule of Other Payables and Accrued Liabilities (Details) - USD ($)
Sep. 30, 2019
Jun. 30, 2019
Other Liabilities Disclosure [Abstract]    
Accrued audit fees $ 2,500 $ 20,000
Accrued professional fees 6,417
Deposit received from customer 77,962 78,231
Others 36,413 12,360
Total payables and accrued liabilities $ 123,292 $ 110,591
XML 68 R9.htm IDEA: XBRL DOCUMENT v3.19.3
Investment in Marketable Securities
3 Months Ended
Sep. 30, 2019
Investments, Debt and Equity Securities [Abstract]  
Investment in Marketable Securities

3. INVESTMENT IN MARKETABLE SECURITIES

 

(i) On May 17, 2018, the Company purchased common stocks in Greenpro Capital Corp. for $500,000 at purchase price of $6 per share.
   
(ii) On October 16, 2018, the Company purchased common stocks in Greenpro Capital Corp. for $1,000 at purchase price of $0.03 per share.

 

    As of
September 30, 2019
    As of
June 30, 2019
 
Cost of investment   $ 501,000     $ 501,000  
Less: Impairment in cost of investment     (366,834 )     (366,834 )
Investment in marketable securities   $ 134,166     $ 134,166  

XML 69 R43.htm IDEA: XBRL DOCUMENT v3.19.3
Prepayments and Deposits - Schedule of Prepaid Expenses and Deposits (Details) - USD ($)
Sep. 30, 2019
Jun. 30, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Prepaid expenses $ 12,420 $ 21,081
Deposits to supplier 349,629 477,254
Total prepaid expenses and deposits $ 362,049 $ 498,335